Dr. Moinuddin

Ph.D. is currently working as Professor in the Department of Biochemistry at the Jawaharlal Nehru Medical College, AMU, Aligarh (U.P.).

He has also served as Chairperson of the Department. Dr. Moinuddin possesses around 30 years of teaching and research experience and has published 120 papers in high impact International journals like FEBS Letters, ABB, BBRC, Rheumatology, Seminars in Cancer Biology, PLoS One, IUBMB Life, Int J of Biological Macromolecules, Frontiers in Chemistry etc. and 06 publications in National journals, besides over 80 presentations at national and international conferences. The average impact factor for his publications comes to be 4.16 with an H-index of 31. His work has been immensely cited by the workers across the globe. He has delivered over two dozen invited talks and chaired as many sessions at scientific meetings, both national and international. Dr. Moinuddin has supervised 25 students for their Ph.D.; M.D. & programme and has operated 05 major research projects. He has also mentored post doctoral students for Dr. D.S. Kothari Fellowship. He is on the review board of over a dozen reputed journals as well as on the DST-SERB reviewer panel. He has also served as subject expert on various selection boards like AIIMS Delhi, KGMU, JK PSC etc. He is currently an elected member on the Executive Council of the Aligarh University and has also served as member of the University Court and the Academic Council. Dr. Moinuddin is a Life member of Society for Free Radical Research (SFRR-I) and Indian Academy of Biomedical Sciences (IABS). He is recipient of prestigious Commonwealth Academic Fellowship (CSC, UK) and also conferred fellowship of Indian Academy of Biomedical Sciences. Dr. Moinuddin was Joint Organizing Secretary for UPACBICON-2008 and Organizing Chairperson for NATCON-2019.

Fields of interest are, Nucleic Acid Immunology, Autoimmunity and Free Radical Biology.

Dr. Alpana Sharma

Affiliation:

• Ex-Professor, Department of Biochemistry, AIIMS, New Delhi
• Area of research: Tumor Biology and Immunology
• Fellow of National Acad. of Med Sciences (FAMS)
• Fellow of Indian Acad. of Biomedical Sciences (FIABS)

Awards/Honors:

• IIS Senior Scientist Oration Award 2024
• KL Gupta Oration Award, ACBICON-2023
• IIS- Polyphenolix Best Senior Immunology Teacher Award 2023
• Prof Sohail Ahmad Award of Excellence in Basic Science Res 2022
• AIIMS Excellence award in Basic Science Res. 2021, 2018, 2016
• AIIMS Oncology Res Award 2020
• AACR International Investigator Award 2012
• Travel Award by IGCS (US) 2012
• Indo-French Fellowship

Publications:

• 150 + peer reviewed Research papers
• Edited 2 text books on Immunology
• 28 chapters contributed for various books

Chief Supervision: 19 PhDs, 17 MSc, 5 MD students

Social Contributions: Written books on Immunology awareness and Cancer awareness for School Children in English & Hindi

Dr. Kannan Vaidyanathan

Professor & Head, Dept of Biochemistry, Believers Church Medical College Hospital (BCMCH), Tiruvalla since February 2022; Fellow, Royal College of Physicians (Edinburgh) (UK) [FRCP (Edin.) (UK)]; President (Association of Clinical Biochemists of India (ACBI). He was Professor, Department of Biochemistry & Head, Molecular Biology, Amrita Institute of Research Center (AIMS), Kochi (2019-2022), Professor & Head, Dept of Biochemistry & Deputy Medical Superintendent, Pushpagiri Institute of Medical Science, Tiruvalla (2013-2019); Head, Metabolic Disorders Laboratory, AIMS & Deputy Technical Manager of Amrita Laboratory Services (2006-2013). He has also worked at Govt. Medical College, Kottayam and Kochi.

APFCB (Asia Pacific Federation of Clinical Biochemists) International Silver Jubilee scholarship, November 2007.
“KP Sinha – PS Krishnan Award” - Best Paper award for best original research paper published in Indian Journal of Clinical Biochemistry published for the year 2011.
ICMR Travel Fellowship to attend EuromedLab Barcelona 2019, 23rd IFCC-EFLM Conference on Clinical Chemistry, Barcelona, Spain on 19th – 23rd May 2019.
“Trialect” Priority Fellowship – Short-term Fellowship at Torino University, Italy (October 2023) (Under Dr. Chiara Riganti).
Co-Editor-In-Chief, eJIFCC & EC Member, CPD (IFCC).
Associate Editor, Indian Journal of Clinical Biochemistry (IJCB) Indexed in PubMed Central and published by Springer.
Associate Editor, Clinical Biochemists Reviews (CBR) Published by APFCB (Asia Pacific Federation of Clinical Biochemists).
Consultant, IFCC-ISNS TF-NBS Task Force.
Member, PG Board of Studies, Kerala University of Health Sciences (KUHS), Kerala.

Dr Jairam Rawtani
Senior Professor and Ex HOD
Department of Biochemistry
Government Medical College Kota Rajasthan

Published 20 Papers and One Book Associate Editor IJCB Ex Vice President ACBI State Representative Rajasthan Joint Secretary Rajasthan ACBI Organized CME and state conferences.

Dr.ANISSA ATIF MIRZA
Head of Biochemistry AIIMS Rishikesh

• Total 27 Years of Teaching and Research Experience in field of Medical Biochemistry
• Established and Developed Academics, Diagnostics and Research of Biochemistry Department at AIIMS Rishikesh since 2012
• Associate Dean Exam, Chairperson of Ph D Committee, Member of PG Thesis Review Committee of Research
• Area of Research Interest: Cancer Biochemistry, Naturobiochemistry and Preventive Biochemistry through behavior
• Working on Collaborative Intramural and Extramural Research projects
• Approximate 90 Research Publications in Research Journals
• Awarded as best Teacher of Biochemistry in 2021 during Teachers Day Celebration of AIIMS Rishikesh
• Received Best Researcher award in 2022 during Research Day Celebration at AIIMS Rishikesh
• Worked to initiate DM course - Metabolic Medicine in Biochemistry

Dr.Sheikh Mumtaz Hadi
I possess more than 40 years experience of teaching and research in Molecular Biology. A number of these years were spent in laboratories in the USA, Switzerland and the UK. In Switzerland I had the occasion to work in the laboratory of Nobel Laureate Dr. W. Arber (discoverer of restriction enzymes) at the University of Basel.

My entire research career has been in the area of structure and function of nucleic acids. As evidenced by my publications I have contributed significantly in the areas of DNA repair enzymology, DNA restriction and modification enzymes and recombinant DNA techniques. For the past several years I have been interested in DNA damage mechanisms involved in chemically induced carcinogenesis and chemopreventive mechanisms.

Specifically we have been studying the mechanism of action of certain dietary and naturally occuring polyphenolics and antioxidants. Our studies have shown that several of the known biological antioxidants are themselves capable of DNA damage under appropriate conditions. Further, it is now recognised that considerable DNA damage may be caused by endogenous metabolites formed during the body’s normal metabolic processes. Such damage is considered to possibly define the base line of the induction of human cancer. We have shown that metabolites such as L-DOPA, bilirubin and uric acid are capable of oxidative DNA damage giving rise to modified bases. Studies with plant derived polyphenolic compounds such as tannins and stilbenes have indicated that the prooxidant action of these compounds is likely to be the mechanism involved in apoptosis induction observed in various cancer cell lines. During the course of such studies a number of papers have been published in journals of repute and several students have obtained Ph.D. degree.

Citation Award: I was awarded as the top ten cited author by Elsevier for our paper entitled “Oxidative breakage of cellular DNA by plant polyphenols: A putative mechanism for anticancer properties” published in Seminars in Cancer Biology 17 (2007) 370–376

Dr.Anil Chuturgoon
Dr Anil Chuturgoon is a Medical Biochemist and has a PhD in toxicology (food mycotoxins) and epigenetics. He is Professor and Head of Medical Biochemistry and is currently the Dean of Research in the College of Health Sciences (University of KwaZulu-Natal, Durban, South Africa). He is a B rated medical scientist by the National Research Foundation; has published over 200 research papers, 12 chapters in books, edited two books and many conference proceedings. He has an H-index of 34. He is actively researching epigenetic phenomena in toxicology and its implications in human diseases. He is an expert on mycotoxins and their biological toxicity in humans. He pioneered research on fusariotoxins and epigenetics and their implication in disease. His contribution to Toxicology has been recognised by CTD curator (supported by the National Institute of Environmental Health Sciences, USA) where 8 of his manuscripts are included in this database. This database provides manually curated information about chemical–gene/protein interactions, chemical–disease and gene–disease relationships. He has successfully supervised and graduated over 150 Master's and 50 PhD students. He serves as editor on several prestigious journals; is a member of the South African Society of Biochemistry and Molecular Biology and executive member of South African Society of Clinical Biochemists. He is an avid mountain biker.

Dr.Bernard GOUGET

Dr Bernard GOUGET
President, National Committee for the selection of Reference Laboratories, DGS-PP1-Ministry of Health and Prevention
Past-President-Healthcare Division Executive Committee, Comité Français d’accréditation (Cofrac)
Secretary, IFCC Emerging technologies Division Chair, IFCC-TF on History
b.gouget@icloud.com

Dr. Bernard Gouget, Ph.D, MSc, LL.D. is past President-Healthcare Division Executive Committee, Comité Français d’accréditation (Cofrac) and President, National Committee for the selection of Reference Laboratories, Ministry of Health. He was associate Professor at the Faculty of Medecine Necker-Children Hospital Centre University Paris and Counsellor for public health at the Fédération Hospitalière de France (FHF) until 2019. Academically, Dr. Gouget has also received a Master in Health economy and a doctorate in Economy and Law.

His professional and research interests include organ physiology in intensive care and the adaptation of health care services to required standards of patient care, disruptive technologies, biomedicine and ethics. He started with IFCC in the beginning of the 90’.Over the past 30 years, he has participated in a number of medical committees and panels at national and international levels as SFBC-EFCC/EFLM representative ( 2005-2016); Chair-EFCC WG on Communication (2010-2011); LABAC-EFLM representative since 2018. He was IFCC-CPD chair (1998-2003), Member and Treasurer at the IFCC-EB (2009-2014), Chair of the IFCC Nomination committee (2015-2017). As current Chair of the TF on IFCC History, he is writing the IFCC's anniversary book. He was President of EuroMedLab Paris 2015 and President of the IFCC General Conference Madrid 2016.

As President of IFCC C-MHBLM (2018-2023) and currently Secretary of the IFCC Emerging Technologies Division since 2024, he works on AI and quantum analysis, smart technologies and quality management that are transforming the traditional healthcare system in a global way and making laboratory medicine more practical, efficient and personalized for sustainable development in the digital decade of the 2020s and beyond .

Dr. Christa M. Cobbaert

Christa M. Cobbaert, PhD, EurSpLM, is a Professor of Clinical Chemistry and Laboratory Medicine in the Department of Clinical Chemistry and Laboratory Medicine at Leiden University Medical Centre (LUMC), Leiden, the Netherlands. She has been heading the department since 2009.

Dr. Cobbaert is a European Specialist in Laboratory Medicine. Her research focuses on Precision Diagnostics, utilizing quantitative bottom-up proteomics to refine the molecular definition of Health and Disease. She currently chairs the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Scientific Division Executive Committee, which is involved with metrological traceability of test results and standardization of medical tests (IFCC Scientific Division). She is also a member of ISO TC 212 working group 2 on Reference Systems and a personal member of the EURAMET Research Council.

In Europe, she represents the European Federation in Laboratory Medicine (EFLM) in the IVD subgroup of the Medical Device Coordination Group during meetings with the European Commission on the implementation of the IVDR 2017/746. In this capacity, she chairs the EFLM Task Force on European Regulatory Affairs (EFLM Task Force).

Her work has resulted in approximately 230 original publications, multiple lectures/webinars, and several appointments to (inter)national positions due to her expertise in precision diagnostics using quantitative bottom-up proteomics and in metrology and reference standardization of medical tests.

Dr. Damien Gruson

Professor Damien Gruson serves as the Head of the Department of Laboratory Medicine at the Cliniques Universitaires Saint Luc in Brussels. Additionally, he holds teaching position and a membership in the research unit focusing on Endocrinology, Diabetes, and Nutrition at UCLouvain .

He holds the esteemed position of Chair within the division on Emerging Technology at the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Furthermore, Professor Gruson serves as a board member for the Royal Belgian Society of Laboratory Medicine and of the Belgian Thyroid Club. Dr. Gruson holds fellowships in the European Society of Cardiology, the Heart Failure Association, and the American Association of Clinical Chemistry Academy. Notably, Professor Gruson is the President of the upcoming Euromedlab Congress scheduled to be held in Brussels in 2025

Dr. Harjit Pal Bhattoa

Cvs : Dr. Dr. Harjit Pal Bhattoa, MD, PhD, MSc, DSc graduated from the Medical Faculty of the University of Debrecen, Hungary and is a Specialist in Laboratory Medicine and a Sub-Specialist in Laboratory Immunology and Hematology. He is the Head of the Endocrinology Unit at the Department of Laboratory Medicine at University of Debrecen. His major research interests are markers of bone turnover and vitamin D. He has been involved in numerous studies on primary and secondary osteoporosis. He has published over a 100 peer-reviewed papers, authored 1 book and 9 book chapters.

He serves as an Advisor to the European Commission in the field of medical devices and in vitro diagnostic medical devices. He is a Full-Member of the International Federation of Clinical Chemistry (IFCC) Scientific Division Committee on Bone Metabolism (IFCC C-BM) and IFCC Executive Committee of Communications and Publications Division (IFCC CPD). He is a Full-Member of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Communications Committee (EFLM C-C) and Task Force European Regulatory Affairs (EFLM TF ERA). He is the co-Editor-in-Chief of the Electronic Journal of the International Federation of Clinical Chemistry (eJIFCC) and the Editor of the EuroLabNews, the official newsletter of the EFLM.

Dr. SEDEF YENICE, M.Sc, Ph.D, MBA

Dr. Sedef Yenice is a distinguished professor of biochemistry and clinical laboratory medicine with over thirty-nine years of extensive experience. Her teaching repertoire includes courses in clinical and molecular biochemistry and laboratory management. Throughout her illustrious career, she has held several key leadership positions including Director of Central Clinical Laboratory Services, Head of the Department of Biochemistry, and currently Deputy Director of the Tissue Typing Laboratory at Florence Nightingale Hospital in Istanbul, Turkey. Dr. Yenice's exceptional contributions to science have been recognized by numerous national and international awards. She is a prolific author with more than 150 publications in prestigious peer-reviewed journals.

Leadership and Service
Dr. Yenice's leadership skills go far beyond her institutional responsibilities. In addition to her roles in the Ministry of Health and the Turkish Biochemical Society, she served as Chair of the IFCC Clinical Laboratory Management Committee from 2014 to 2019, which underscores her commitment to advancing the field at a global level. She is also actively involved in the IFCC Education and Management Division, is a member of the Executive Committee, and leads the Visiting Lecturer Program.

In addition to her work at the IFCC, Dr. Yenice chairs the Continuing Professional Education Credit System (CPECS) Task Force of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), where she advocates for continuing professional education and the pursuit of excellence in laboratory medicine throughout Europe. She is also a valued member of the Clinical and Laboratory Standards Institute (CLSI) Expert Panel on Clinical Chemistry and Toxicology, contributing her expertise to the development of standards and guidelines that shape clinical laboratory practice.

Contributions and Impact
Dr. Yenice's diverse contributions to clinical laboratory medicine reflect her unwavering commitment to advancing laboratory medicine, fostering international collaboration, and disseminating excellence in clinical laboratory practice. Her work continues to influence and inspire professionals in the field, both nationally and internationally.

Dr. Joris R. Delanghe

Joris, Richard, Siegfried Delanghe -medical studies Ghent University, 1975 1982 1982-1987: training in laboratory medicine (Bruges, Leuven, Ghent, Stuttgart) doctor in biomedical sciences (PhD, Ghent University), 1987
-aggregation for higher education in laboratory medicine (Ghent University), 1989 professor in clinical chemistry (Ghent University) since 1994 visiting professorships in Lithuania, Zimbabwe, China, Rwanda, Congo, Palestine major research interest: kidney function, iron metabolism, plasma proteins, clinical chemistry in developing countries

author of more than 630 scientific papers and 24 chapters in books,
promoter of 28 PhD thesisses, holder of 8 patents
past-president Belgian society for clinical chemistry member of the creatinine standardisation group of the National Kidney disease education program (NKDEP) (USA)
member of the IFCC/WASPaLM Working Group on Chronic Kidney Disease (WG-CKD)
co - editor in chief of “Clinica Chimica Acta”, editor-in-chief of “Acta Clinica Belgica”
2019: EFLM Scientific Award for Laboratory Medicine -

Dr. Merve Sibel Gungoren

She was graduated from Hacettepe University School of Medicine in Turkey. During her undergraduate studies, she attended MD-PhD programme of the same medical school and obtained her PhD degree in Biochemistry. She completed her medical residency at Hacettepe University School of Medicine Department of Medical Biochemistry. She also attended Bilkent University and obtained Executive MBA degree. During 2016-2022, she worked at Duzen Laboratories Group and had an adjunct role at Medipol Ankara University. Curently, she works as the head of Central Laboratory at Mamak State Hospital.
She volunteered for EFLM Communication Committee and Working Group on Promotion and Publications (WG-P) from 2015 to 2020 and was the Chair of EFLM WG-P from 2017 to 2020. Since February 2020, she is a full member of IFCC Committee on Clinical Laboratory Management (C-CLM).
She is a member of Editorial Board in Turkish Journal of Biochemistry and an ISO 15189 auditor in Turkish Accreditation Agency. She is also a lead auditor for ISO 27001 Information Security standard at national level.

Dr.Hari K Koul

Hari K. Koul, M.Sc., Ph.D. FACN, FASN Louisiana University Health Sciences Center- New Orleans-LA
Dr. Hari K. Koul is Professor in the Departments Interdisciplinary Oncology, Biochemistry and Molecular biology and Urology. He serves as Associate Director for the LSU-LCMC Cancer Center and Head of the GU Oncology Research Program at LSUHSC. He is recognized as one of the leading translational researchers in urologic diseases. He is listed among the top 2% of scientists in the world for 2024 (https://www.adscientificindex.com/scientist/hari-koul/1355019 ). His current research interests are focused on GU oncology with special emphasis on understanding the pathophysiology of prostate cancer. Over the past three decades, Dr. Koul has greatly contributed to our understanding of molecular mechanisms, in oxalate nephron-toxicity and prostate cancer. Dr. Koul’s research is focused on understanding the mechanisms tumor progression and emergence of therapeutic resistance, with special focus on epigenetic mechanisms.

Dr. Koul earned B.Sc. (Biology and Chemistry) 1984 and M.Sc. (Biochemistry) 1986 from Kashmir University-Srinagar, India, and Ph.D. (Biochemistry) 1990 from PGI, Chandigarh, India. Dr. Koul worked as a postdoctoral fellow (1991-1995) and Instructor (1996) at the UMASS Medical School, Worcester, MA. Dr. Koul received his first independent NIH RO1 in 1996 and relocated as Sr. Staff Scientist to Henry Ford Health Sciences Center, Detroit MI. In 2003 Dr. Koul was recruited as Professor and founding Director of Urology Research at the University of Colorado Denver, School of Medicine. In 2013, Dr. Koul was recruited to LSUHSC-S as Professor with tenure and Carroll W. Feist Endowed Chair in Cancer. He also served as Chairman of the Department of Biochemistry and Molecular Biology, School of Medicine and Associate Director for Basic and Translational Research of the Feist Weiller Cancer Center at LSUHSC-Shreveport. Dr. Koul was recruited to LSUHSC-New Orleans on 02/2020.

Dr. Koul is a tireless advocate for scientific research enterprise and is a thought leader. In recognition for his scientific contributions, tireless service and research leadership Dr. Koul has been elected, President of the Society of Basic Urology Research (Home (sbur.org) ) USA (2016-2017), President of the Research on Calculous Kinetics Society (ROCK - Welcome (rocksociety.org) ) USA (2005-2006), Fellow of the American Society of Nephrology (2010), and A Fellow of the American College of Nutrition (2004) and Co-Chair of the American Urological Association Research Grants Committee (2014-2015). He served as charter member of the American Urological Association Research Council (2007-2013; 2016-2018) and Member-at-Large/ Board of Directors of the Society of Basic Urological Research. He is recipient of Outstanding Achievement Award of the Society of American Asian Scientists in Cancer Research (2009). Charter Member of the NIH Study Section on the Urologic Kidney and Genitourinary Development (2003-2007) and US Veterans Administration Merit Review Subcommittee for Oncology (2004-2009). He also served as a member of the US Veterans Administration Merit Review Subcommittee for Surgery (2004-2008). He is frequently called to serve as a Chair/member on several NIH and DOD Panels for his expertise and leadership skills.

Dr.Khosrow Adeli

Dr. Adeli is a distinguished clinical biochemist with over 36 years of experience in clinical chemistry, education, and research. He has held numerous leadership roles in clinical biochemistry and laboratory medicine, contributing significantly to research in metabolic health, pediatric laboratory medicine, and genetic-metabolic diseases. Dr. Adeli has authored over 700 publications and abstracts and received numerous national and international awards for his research excellence, including the 2019 ADLM Outstanding Research Award and several others from the Canadian Society of Clinical Chemistry.

Elected as president of the International Federation of Clinical Chemistry & Laboratory Medicine (IFCC) in 2019, he served a three-year term and is currently on the IFCC Executive Board as past president. His research, particularly through the CALIPER studies (www.caliperproject.ca), has been highly influential both in Canada and internationally. Dr. Adeli’s contributions are evident in his extensive list of publications, with 234 peer-reviewed articles and a significant citation impact (Google Scholar: h-index of 54, i10-index of 184, and over 14,000 citations). Additionally, he is a Senior Scientist at the SickKids Research Institute, where his lipid/lipoprotein research has garnered further recognition, including the CSATVB Scientific Excellence Award and multiple Merck Senior Investigator Awards. Dr. Adeli’s work has greatly impacted clinical chemistry through his innovative research, leadership, and dedication to training future clinical chemists.

Dr. Namita Parikshit Mahalle

1) Presently working as Consultant Biochemist in Pathology Department in Deenanath Mangeshkar Hospital & Research Centre, Pune since last 17 years.

2) Previously worked with Research & Development division of Lupin Limited Pharmaceutical Company and also had worked with Poona hospital and Research Center, Pune as Medical Biochemist.

3) Awards: Dr. C. Sita Devi Award Young scientist award (twice), IFCC Task Force Young scientist award, The Global Health Travel Award funded by the Bill & Melinda Gates Foundation to present paper in conferences in China and Brazil, IFCC Roche Travel Scholarship for presenting paper in conferences in Bali, Indonesia and Nutrition Society Travel Fellowship Award to present paper in conference in Ghana, Africa.

4) Several publications in national and international journals.

5) Actively involved in research activities funded by Department of Biotechnology & foreign collaborators Aarhus University & Hospital, Denmark, along with in-house research.

Dr.Neeraj Sharma

Dr. Neeraj Sharma is an Assistant Professor in the Department of Genetic Medicine. He studies molecular genetics of cystic fibrosis (CF) disease. Neeraj received his undergraduate and postgraduate degrees in DVM followed by PhD in genetics of cystic fibrosis from Postgraduate Institute of Medical Education and Research, Chandigarh, India. He completed postdoctoral fellowship under the mentorship of Dr. Garry Cutting in the Department of Genetic Medicine at Johns Hopkins University.

Dr. Uma Kanga

Dr. Uma Kanga is an Additional Professor at the Department of Transplant Immunology and Immunogenetics at the All India Institute of Medical Sciences (AIIMS), New Delhi. She received her doctoral degree from AIIMS and further training at several prestigious institutions including Central Laboratory Blood Bank, Amsterdam; Tokai University, Japan; Children’s Hospital, Oakland, USA; Royal Free Hospital, London, UK; and Necker Hospital, Paris.

**Awards:** Dr. Kanga has been honored with fellowships from the Commonwealth Scholarship Commission (UK), the Japanese Society for Promotion of Science, and the European Board of Surgery, which conferred upon her the title of Fellow of the Board of Surgery in Transplantation Immunology. Her research work has been recognized by the European Federation of Immunogenetics (EFI) and The Transplantation Society (as Mentor-Mentee award).

**Research Interests:** Dr. Kanga's research focuses on the genomic diversity of HLA in the Indian population, molecular basis of disease susceptibility, and biomarkers for predicting transplant outcomes. Her research has received funding from both national and international agencies, and she has 82 publications to her credit. She also teaches medical students (UG & PG) and mentors PhD students.

**Clinical Services:** As the faculty in-charge of the Clinical Immunogenetics Laboratory, Dr. Kanga manages transplant immunology services for both stem cell and renal transplant programs at AIIMS. She has trained several clinicians and laboratory scientists and coordinates the National Quality Assurance Program for molecular-based HLA typing, involving 35 Indian centers.

**Role in National/International Scientific Bodies:** Dr. Kanga is the founder secretary of the Indian Society for Histocompatibility and Immunogenetics (ISHI), a member of the International HLA and Immunogenetics Workshop Council (IHIWS), the General Assembly of the International Union of Immunological Societies (IUIS) (2022-2025), and the Gender Equity Committee of IUIS (2024-2027). She has also served as Chair of the International Committee of the American Society for Histocompatibility and Immunogenetics (ASHI) (2022-2023), Councilor of the Asia Pacific Histocompatibility and Immunogenetics Association (APHIA), and Treasurer of the Indian Immunology Society.

Dr.Pamela Christudoss

Dr. Pamela , Professor and Head of Clinical Biochemistry, CMC, Vellore, has 33 years of experience in the Clin Bio lab, CMC with technical expertise in handling automated, semiautomated analysers for Chemistry and Immunoassays, RIA, ELISA’s, ICP- MS for heavy metals, Atomic absorption and special manual assays for clinically related laboratory tests. She is actively involved in trouble shooting assays, instruments and interpretation of results. Her area of specialization and interest are Protein Electrophoresis for Myeloma work up, Endocrinology, Laboratory Quality management and competency training for staff. She is actively involved in teaching students of various courses both undergraduate and postgraduate. Her PhD research topic was on ‘Tissue trace metal Zinc and colon cancer’ . She has published many papers in both national and International journals and is involved in various Research projects within the institution and multicentric international projects.

She is the Quality manager of the dept and for the EQAS programme and is involved in documents preparation for NABL accreditations. She is involved with the CMC EQAS programme since 14 years .More than 14,000 labs in India and other neighboring countries participate in this Quality programme and is the first in India and the largest EQAS programme in Asia. Her desire to see an improvement in the performance of Lab participants led her to make many changes in the programe to improve its quality. She has been an invited speaker , resource person for various scientific programmes and has conducted many workshops on “Understanding Principles and Practices of QC’ , and ‘Good clinical laboratory practice’ in various states in India.

Dr. Pamela was sent for a ‘Faculty Research Fellowship’ at Kansas University medical centre , USA in 2010, and for ‘Senior Training Fellowship’ on Quality Control at UKNEQAS Birmingham and Guildford, UK in 2018. She is the member of the Advisory committee of the M(EL) T laboratories – Medical –Entry level testing labs with NABL .

Dr.Pavai Sthaneshwar

Dr. pavai Sthaneshwar, graduated from Kilpauk Medical College, Chennai and subsequently did her post graduation from Madras Medical College. Obtained her degree in Medical Education also. She is currently holding the post of Associate Professor in the Department of Pathology. She is the academic person in-charge of Chemical Pathology for the Division of Laboratory Medicine. Her keen interests are improving the laboratory services. She is Vice Chair for MACB CKD task Force, Chair for standardisation of macroprolactin screening and reporting, and a member of national Method verification writing group. In the past she held a post in APFCB CKD Task Force.

Dr.Pradeep Dudeja

Dr. Dudeja’s group has been involved in elucidating ion transport mechanisms in the human intestine for a better understanding of mechanisms underlying pathophysiology of diarrhea and to develop better therapeutic modalities. His group has made significant contributions to the understanding of the role of chloride transporter SLC26A3 or DRA (Down Regulated in Adenoma, the congenital chloride diarrhea gene). He has also established that a down regulation in expression of this chloride transporter in IBD patients, animal models of IBD and in response to infection by food-borne pathogens is one of the key mechanisms underlying pathophysiology of diarrhea associated with IBD and infections by food borne pathogens. His studies have now established that SLC26A3 should be a novel therapeutic target for diarrheal diseases. He has also recently identified several proabsorptive molecules which upregulate intestinal chloride absorption by upregulating its expression or function including lysophosphatidic acid, neuropeptide Y, bioactive factors secreted by probiotics. In addition, his group has done pioneering work in understanding the mechanisms of absorption of colonic short chain fatty acids (SCFAs) produced by bacterial fermentation of undigested fiber in the large intestine. He has shown that SCFA absorption via a monocarboxylate transporter-1 involves a novel nutrient sensing mechanism. He has extensively published his work in respected journals (~ 260 publications to date). He serves as an academic editor for many journals including PLOS1, Pathophysiology and Comprehensive Physiology. He was recently awarded one of the most prestigious “University Scholar” award by University of Illinois at Chicago for 2011. In 2018, he was honored with “Takeda Distinguished Scientist Award” of Amer. Physiol. Soc, and in 2024 he was honored by the research mentor of the year award by intestinal disorders section of American Gastroenterology Association.

Dr.Qing H Meng

Dr. Meng is Professor and the Section Chief of Clinical Chemistry in the Department of Laboratory Medicine at The University of Texas MD Anderson Cancer Center. He also serves as the Director of Clinical Chemistry Postdoctoral Training Program at MD Anderson Cancer Center.

Dr. Meng's research interests focus tumor biology, biomarkers, liquid biopsy, and cancer diagnostics. He has received numerous research grants, including NIH R01 and R21. Dr. Meng has published over 150 peer-reviewed papers. He has given presentations at prestigious national and international conferences. Dr. Meng holds editorial roles as the Associate Editor of Clinical Biochemistry and the Section Editor of Clinical Pathology for Annals of Medicine, and serves on the Editorial Board of CCLM, CCA, CRCLS, and JALM, and among others.

Dr. Meng has played integral roles in various national and international professional societies and organizations including Canadian Society of Clinical Chemists (CSCC), Association for Diagnostics and Laboratory Medicine (ADLM), and IFCC. Currently he is the ADLM (formerly AACC) Academy President, Chair of ADLM Global Lab Quality Initiative (GLQI) Asia Pacific Working Group (APWG), Co-Chair of IFCC Task Force on Global Lab Quality (TF-GLQ), CLSI Expert Panel on Clinical Chemistry and Toxicology, FDA Medical Devices Advisory Committee, Clinical Chemistry and Clinical Toxicology Devices Panel, and WHO IVD advisor.

Dr. Meng has received numerous awards from prominent professional societies, including the AACC, AACC Academy, CSCC, and CACB. Notable accolades include the CSCC Research Excellence Award, CACB Outstanding Service to the Profession of Clinical Biochemistry, the 2021 AACC Academy Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research, and the 2023 Van Slyke Award from the American Association for Clinical Chemistry (AACC) recognizing his outstanding achievements and excellence in research, service, and contributions to clinical chemistry and laboratory medicine.

Dr. Nirupma Trehanpati

Qualifications: MSc, PhD

Current positions: Professor, Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi; Faculty, WHO Collaborating Centre on Chronic Liver Diseases and Viral Hepatitis, New Delhi, India. Contact: trehanpati@ilbs.in, trehanpati@gmail.com, Tel: +91-9540946971, ORCID ID: 0000-0002-6109-0033.

Other Experiences:
• Visiting Scientist in the Department of Pathology, The Center for Systems Immunology, School of Medicine, Case Western Reserve University, from 17th Feb-27th Feb, 2020 under the HIPC collaboration. Indo-US Project
• Visiting Scientist in the Westmead Clinical School, Faculty of Medicine, University of Sydney from 1st-20th Sep, 2018
• Visiting Scientist in the laboratory of Innate Immunology, NIAID National Institute of Health, Maryland, USA, in 2014
• Visiting Scientist in the laboratory of Innate Immunology, NIAID National Institute of Health, Maryland, USA, in 2010
• Visiting Scientist in the laboratory of Innate Immunology, NIAID National Institute of Health, Maryland, USA, in 2007
• Visiting researcher to University of Birmingham, Liver Research Group, Division of Medical Sciences, Birmingham, 2006
• Visiting scholar to German Research Center for Biotechnology, Braunschweig, Germany in 2005
• Vice-Chairperson in IC-SCR of DATT Mediproducts Pvt. Ltd.

Honors:
• Guest Lectures at Westmead Clinical School, Faculty of Medicine, University of Sydney during the visiting scientist tenure in Sep, 2018
• Guest Lecture at Center for Research on Inflammation (CRI), INSERM University of Paris on 25th April, 2017
• Plenary Paper Award in AASLD 2013, USA
• Best Paper in Viral Hepatitis Conference, Frankfurt 2013
• Presidential Paper Award at Prestigious Hepatology meet at AASLD 2012
• Bill and Melinda Gates Travel Grant for the Ninth Annual Conference of Vaccine Research, Baltimore, USA, 11th May 2006
• Travel Grant from HIV and Liver Diseases, Wyoming, 11th-14th Sep, 2006
• Best Paper in Indian Society of Gastroenterology, Nov 2005
• DST Young Scientist, 2003
• CSIR POOL Officer, 1998-2001
• CSIR Research Associate, 1994-1997
• CSIR Senior Research Fellow in Ph.D
• Lady Tata Memorial Fellowship in Ph.D

Contribution to Science:
Total Publications: 114; Career citations >2200; Career citations since 2019 = 750; Total h-index 24; i10 index 37; 5 with >100 cites, 6 with >50 cites. One published article was the subject of editorial commentary (Liver Cancer) and one published article appeared on the cover page of the journal (Hepatology).

Dr. Egon Amann

Egon Amann is an independent consultant in Life Sciences, Quality Systems, and Clinical Chemistry. He is Professor Emeritus at the University of Applied Sciences in Hamm-Lippstadt, Germany, where he was Head (Dean) of the Master Studies “Biomedical Management and Marketing”. He still lectures in Quality Assurance and Product Legislation, Quality and Risk Management, Clinical Chemistry, and Synthetic and Molecular Biology.

Prior to his current posts, he was an Honorary Professor in Molecular Biology and Genetics at Philipps University in Marburg, Germany.

Egon has long-time experience in the pharmaceutical and diagnostic industries. He was an executive employee with Behringwerke AG, Dade Behring Diagnostics, Siemens Healthcare Diagnostics, and Hoechst AG in Germany. He spent many years in human vaccine and human plasma protein R&D and in diagnostic assays development in Germany, Japan, and the US.

Egon has 18 patents granted and more than 80 peer-reviewed publications, along with several book chapters in the areas listed above.

Egon is currently Co-Chair of the IFCC TF-GLQ (Task Force on Global Lab Quality). Previous IFCC assignments included Chair of the Working Group DQCML (Developing Quality Competence in Medical Laboratories) and Chair of C-AQ (Committee on Analytical Quality).

Dr. Ashwin Laxmikant Kotnis

Ashwin Kotnis is Professor of Biochemistry at All India Institute of Medical Sciences Bhopal. He leads an interdisciplinary research team working on predisposition to vitiligo, head-neck cancer, and IgA deficiency diseases funded by DST-SERB, DHR, ICMR, and MPCST in collaboration with several institutes across India.

His interest in onco-immunology and autoimmune disease arose during his PhD at ACTREC, followed by a postdoctoral fellowship at Karolinska Institute, Sweden, and University of Oxford, England, where he published on the role of DNA repair defects in lymphomas and class switch recombination.

As a FAIMER Fellow, he is an avid teacher designing interactive courses on the clinical relevance of lipid metabolism and immunology for MBBS and MD students, along with research mentoring for medical undergraduates. His team’s research has been published, and he has been awarded the EMBO Short Term Fellowship, Lancet Travel Grant, Tata Grant, and other fellowships.

He serves on Ethics and Clinical Trial committees in and around Bhopal and is on the Editorial Review Board of several journals. He guides Postdocs, MD students, Research Fellows, and PhD candidates who have won awards from ICMR, MPCST, and ACBICON for their research papers.

Dr. Swarup A.V. Shah

Dr. Swarup Shah is an experienced molecular scientist with over a decade of experience in molecular diagnostics and omics research, including genomics and transcriptomics. His primary interests focus on translational research, particularly in the field of coronary artery disease, pharmacogenetics, precision medicine, and rare genetic disorders such as familial hypercholesterolemia.

Currently, Dr. Shah serves as a senior molecular scientist at P. D. Hinduja Hospital & Medical Research Centre in Mumbai and is an executive committee member of Emerging Technologies Division of the International Federation of Clinical Chemistry and Laboratory Medicine (EC-ETD, IFCC).

Throughout his research career, Dr. Shah has actively contributed to academia and research and has authored over 30 peer-reviewed publications, with more than 700 citations. He played a key role in conducting the first comprehensive reference interval study for over 50 biochemical analytes in healthy Indian volunteers, as part of the IFCC's global reference interval study led by the IFCC C-RIDL committee.

Dr. Shah’s research has been recognized through numerous national and international awards including the Young Scientist Award from APFCB, Best Poster Award from the European Society of Pharmacogenomics and Personalised therapy (ESPT) along with multiple international travel awards from organizations such as IFCC, APFCB, AMP etc. Dr. Shah is also a recognized PhD mentor at the University of Mumbai and serves as principal investigator for several ICMR-funded research projects.

Additionally, he is a member of various scientific organizations such as ADLM, CPIC, APSAVD, ACBI etc. Dr. Shah serves on the editorial boards of notable journals such as Clinical Chemistry and Laboratory Medicine (CCLM) and is also a reviewer for several prominent international journals.

Dr.Rajvir Dahiya

Dahiya finished his PhD in 1983 in the field of Experimental Medicine from Post Graduate Institute of Medical Education and Research Chandigarh, India. After completing his PhD, Dahiya joined the University of Chicago Pritzker School of Medicine and did his postdoctoral fellowship in medical oncology and molecular biology. After completing his fellowship, Dahiya joined UCSF School of Medicine and San Francisco Veterans Affairs Medical Center (VAMC) in 1987. Dahiya received his M.D. from the Kagoshima University Faculty of Medicine, Kagoshima, Japan and D.Sc. from the Osaka University Graduate School of Medicine, Osaka, Japan. He became director of Oncology Urology Oncology Research Center at the UCSF/VAMC in 1991. After 34 years of service at the UCSF, he retired as a Professor Emeritus and Director of Urology Research Center. Also retired as a Senior Research Career Scientist from the Department of Veterans Affairs, Washington DC. Dahiya has published more than 600 original research manuscripts. Dahiya’s world ranking in medicine is 4759 and USA ranking is 2644 with more than 36,500 research citations and D-index of 107 in 2024. He has written books and holds multiple patents in oncology. Based on the NIH and VA data base NIH Reporter and Grantome, Dahiya's research programs were supported (99 times awarded) by the NIH and VA. Dahiya was a scientific adviser to the President of India Dr. A.P.J. Abul Kalam (11th President of India from 2002-2007). Dahiya is an Associate Editor of Clinical Cancer Research (2012-present) an Academic Editor of “PLoS ONE, (2012-present), a senior academic editor of American Journal of Cancer Research. (2015-present) and was an Associate Editor of Cancer Research (2000-2012).

In 2021, Dahiya started a company named 'Geneverify Inc' in the USA, focusing on developing gene-based testing for screening, early diagnosis, prognosis, treatment follow-up, and gene therapy for various cancers. He has received five USA patents for this technology and is working with the Government of India to transfer this technology, which could save the lives of millions of cancer patients.

: Dr.Suresh Kumar Verma

Dr. Verma is an Associate Professor in the Department of Medicine at the University of Alabama at Birmingham. Trained in biochemistry, Dr. Verma earned his PhD from the Department of Biochemistry at PGIMER Chandigarh in 2007. He completed postdoctoral training first at the Cardiovascular Research Institute, Texas A&M, focusing on Renin Angiotensin signaling in cardiovascular disease, and later at Northwestern University's Department of Medicine, investigating inflammation's role in heart failure progression. Recognized for his exceptional performance, Dr. Verma was promoted to Assistant Professor at Northwestern University in 2012.

In 2014, Dr. Verma received a prestigious Scientist Development grant from the American Heart Association to study the role of bone marrow progenitor cells in cardiac fibrosis and heart failure progression in hypertrophic HF models. He subsequently joined Temple University, Philadelphia, as an Assistant Professor. Currently, Dr. Verma holds dual appointments as an Associate Professor of Medicine and Biomedical Engineering at the University of Alabama at Birmingham, Birmingham Alabama, where he also serves as Director of the Fellows Research Seminar Series.

Dr. Verma's research focuses on identifying novel signaling mediators in cardiovascular disease regulation. His laboratory is supported by major federal agencies and private foundations, resulting in over 55 publications in high-impact journals such as Circulation, Circulation Research, Cardiovascular Research, and Nature Communications. He has mentored more than 25 students and fellows and has received numerous awards, including the AHA Outstanding Early Career Investigator Award.

Dr. Kalyan Goswami

Dr. KALYAN GOSWAMI, MBBS, MD (Biochemistry)

More than 24 years of professional experience after MD degree from Institute of Medical Sciences, Banaras Hindu University. Presently, Professor & Head, Department of Biochemistry and Dean, Academics, AIIMS Kalyani.

Research interest: Oxidative, glycative & metabolic stress, apoptosis & immunomodulation for drug development, bio-statistical application in quality control; non-conventional & integrated teaching in medical education.

Completed 4 projects and presently involved in 4 other ongoing projects from ICMR, DHR and DST.

Fellow of FAIMER (Federation for Advancement of International Medical Education and Research); Trained from National teachers’ training Centre, JIPMER, Puducherry.

Trained in Applied aspects of Biostatistics from Human Genetics Unit of Indian Statistical Institute, Kolkata.

Trained in ‘Qualitative Methods in Health Research’ at Sushila Nayar School of Public Health, MGIMS. Participated in ‘Ethics in clinical research’ from KEM, Mumbai.

Served as Secretary, Institutional Ethics Committee, MGIMS, Sevagram.

Trained in ‘Quality Control and Method Validation’ by CDC, Atlanta, USA and ‘Labs for Life’ programme of Ministry of Health & Family Welfare, Govt. of India in New Delhi. Resource person for training of Lab personnel in statistical quality control at various national level workshops.

Editorial-board member: Indian Journal of Clinical Biochemistry.

Reviewer-STRIDE scheme projects under UGC and SPARC scheme projects of IIT.

Member of ICMR National Taskforce for establishment of Reference interval in Indian Population.

Published 105 Articles (85 International) with more than 2200 citations; h index-25.

Contributory editor: Lippincott’s Illustrated review of Biochemistry, South Asian Edition, 2020. Authored chapters in 4 books.

One United States Patent in credit: Novel diagnostic marker, a diagnostic kit, and a method for diagnosis of rheumatoid arthritis. Two other patents filed.

Dr. Emma English

Dr. Emma English completed her PhD in Biochemistry and undertook Clinical Scientist training at Addenbrooke’s Hospital in Cambridge, holding HCPC registration. After several years at Addenbrooke’s, she transitioned to higher education to support the learning of those passionate about clinical laboratory medicine. Emma then moved to the University of Nottingham, School of Graduate Entry Medicine, to develop new courses for scientists and health professionals.

Emma has extensive experience teaching and learning across a wide range of health programs at both undergraduate and postgraduate levels. While at the School of Health Sciences at UEA, she served as Director of Postgraduate Research and as the academic lead for course development from concept through to accreditation. She is now the Head of the Medicine, Health and Life Sciences portfolio at the University of Cambridge, Institute of Continuing Education.

In her broader educational roles, Emma chairs an IFCC international education committee on diabetes biomarkers. This committee collaborates with global stakeholders to develop and implement effective diabetes testing methods. Her work particularly focuses on enhancing diagnostic provision in low-resource settings. Emma has numerous publications in this area and is a lead author on global guidelines for quality testing of diabetes, including several key World Health Organization (WHO) publications. She also serves as a consultant to WHO and other health-related NGOs.

Dr. Emma English

Dr. Emma English completed her PhD in Biochemistry and undertook Clinical Scientist training at Addenbrooke’s Hospital in Cambridge, holding HCPC registration. After several years at Addenbrooke’s, she transitioned to higher education to support the learning of those passionate about clinical laboratory medicine. Emma then moved to the University of Nottingham, School of Graduate Entry Medicine, to develop new courses for scientists and health professionals.

Emma has extensive experience teaching and learning across a wide range of health programs at both undergraduate and postgraduate levels. While at the School of Health Sciences at UEA, she served as Director of Postgraduate Research and as the academic lead for course development from concept through to accreditation. She is now the Head of the Medicine, Health and Life Sciences portfolio at the University of Cambridge, Institute of Continuing Education.

In her broader educational roles, Emma chairs an IFCC international education committee on diabetes biomarkers. This committee collaborates with global stakeholders to develop and implement effective diabetes testing methods. Her work particularly focuses on enhancing diagnostic provision in low-resource settings. Emma has numerous publications in this area and is a lead author on global guidelines for quality testing of diabetes, including several key World Health Organization (WHO) publications. She also serves as a consultant to WHO and other health-related NGOs.

Dr. Naresh Sachdeva

Affiliation: In-charge - Endocrinology and Molecular Immunology Laboratory, Department of Endocrinology, PGIMER, Chandigarh, India.

Experience: Postdoctoral Fellow - University of Miami, FL, USA and Visiting Professor at St Vincent’s Institute, Melbourne, Australia.

Research Interests: Pathogenesis and exploration of immunotherapeutic approaches in Type-1 Diabetes.

Publications: Over 175 papers and a US patent. H-index: 41.

Awards: Trust For Education and Training in Flowcytometry (TETC) Best Published Paper Award 2024, Distinguished Alumnus Award, Panjab University 2023, Chellaram Foundation Diabetes Research Award and Gold Medal, 2019, BD Biosciences Research Award, 2011, R. Nath Gold Medal in Biomedical Sciences, 2004.

Member Editorial Board: Frontiers in Endocrinology, World Journal of Immunology, Journal of Pediatric Endocrinology.

Reviewer: DST-SERB, CSIR, DBT, ICMR and various Academic Journals.

International Collaborations: Boston University, Boston, USA; St Vincent’s Institute, Melbourne, Australia; Drexel University, Philadelphia, USA.

Dr. Medha Rajappa

Dr. Medha Rajappa is a Professor of Biochemistry and Coordinator of the Bioinformatics Facility at Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) in Puducherry, an Institution of National Importance under the Ministry of Health and Family Welfare. Dr. Rajappa plays a pivotal role in educating and mentoring medical students, residents, and fellows. She is also the Principal Investigator for several projects in cutaneous immunology and chronic kidney disease biology, funded by ICMR, SERB, DBT, and others. Her research focuses on improving diagnostic accuracy and developing novel biomarkers to enhance outcomes in inflammatory skin disorders and chronic kidney disease.

Dr. Rajappa has published 120 research articles with a total citation count of 3282, an h-index of 33, and an i10-index of 75. She has received numerous awards at both national and international levels, including the JIPMER Faculty Research Award-Basic Sciences 2023-2024; Supervisor for ICMR CNMC STS Excellence Award 2019; Mrs. & Dr. G. P. Talwar Oration Award-2023 at ACBICON-2023; Dr. G. P. Talwar Mid-Career Scientist Award in 2017; Outstanding Clinical Researcher of the Decade Award at the 4th National Evidence-Based Medicine and Clinical Research Conference; Kusum Sharma Award from the Indian Academy of Biomedical Sciences in 2015; and several travel grants and research awards.

She served as Associate Dean (Research) from 2019-2023, significantly contributing to research capacity building at JIPMER. Dr. Rajappa is dedicated to enhancing patient outcomes through her expertise, commitment to high-quality patient care, and contributions to research and academia.

Dr. Sergio Bernardini

Dr. Sergio Bernardini, MD, PhD

• Post Graduated in Pediatrics and in Clinical Biochemistry and Chemistry
• Master in Health Economy and Management
• Full Professor in Clinical Biochemistry and Clinical Molecular Biology at the University of Tor Vergata, Department of Experimental Medicine, Via Montpellier 1, cap 00133; Rome, Italy
• Publications H Index: 52
• Head Physician of Laboratory Medicine Department at the Tor Vergata University Hospital, Viale Oxford 8, cap 00133, Rome, Italy
• Past President of the Italian Society Clinical Biochemistry and Laboratory Medicine (SIBioC) 2018-2019
• Past Secretary of the International Federation Clinical Chemistry and Laboratory Medicine (IFCC) 2012-2017
• Chair of the IFCC Emerging Technologies Division 2018-2023
• IFCC Secretary 2024-2026

Contacts:
Mobile: +39 3804399292
Office: +39 0620902262
Mail: sbernardini.med@gmail.com

: Dr. Shyamali Pal

"Dr. Shyamali Pal is PhD Biochemistry with experience in the field of laboratory medicine for more than 40 yrs. She is currently Consultant Biochemist & Technical Director in Allergimmuno Diagnostics Private Limited. She is Lead assessor in NABL and Assessor for medical laboratory, Proficiency testing and Calibration Reference Material in IAS, USA. She is corresponding member of Task Force, Global Lab Quality, IFCC, member of Technical Inspection Committee of IAS, USA. Dr Shyamali Pal is Fellow of ACBI, Pattabiraman Oration awardee, PT provider of an accredited Proficiency testing scheme, PRE-EQC. "

Dr. Tahir Pillay

Prof Tahir Pillay is Professor and Head of the Department of Chemical Pathology and overall Pathology Head, University of Pretoria & National Health Laboratory Service(NHLS), Honorary Professor of Chemical Pathology, University of Cape Town (UCT) in South Africa. He is also Chair of the Communications and Publication Division(CPD) of the International Federation of Clinical Chemistry & Laboratory Medicine (IFCC), the first person from Africa to lead a division of the IFCC in its 75 year history. He is also currently the highest research rated chemical pathologist in South Africa by the National Research Foundation, South Africa. He is a board member of the World Association of Pathology & Laboratory Medicine (WASPALM) and the Medical Research Council(MRC), South Africa. He is also one of only two pathologists in South Africa who is an elected member of the Academy of Science of South Africa.

He is a former Editor-in-Chief of the Journal of Clinical Pathology. Prof Pillay has an MBChB cum laude ( University of Natal ), PhD in biochemistry ( University of Cambridge). He completed his postgraduate specialist training at Imperial College and postdoctoral training in molecular and cellular endocrinology at University of California San Diego. He is a Fellow of the Royal College of Pathologists, London and the College of Pathologists, South Africa. Prof Pillay’s research publications spans molecular cell biology of insulin signalling and insulin resistance, molecular modelling of ligand-receptor complexes and application of new diagnostic methods for lipid disorders. He is also a chapter author in the latest editions of the Tietz Textbooks of Laboratory Medicine and the Tietz Fundamentals of Laboratory Medicine.

In 2023 and 2024, he was listed in the Pathologist magazine Power List as one of the Top 100 most influential people in pathology – specifically, as one of the Top 20 Champions for Change.

Dr. Tjan Sian Hwa

Education

• Medical Doctor from Faculty of Medicine – University of Indonesia, Jakarta, Indonesia
• Master of Science in Clinical Tropical Disease from Mahidol University – Bangkok, Thailand
• Clinical Pathologist from Faculty of Medicine – University of Indonesia, Jakarta, Indonesia

Current Positions and Activities

• Head of Clinical Laboratory Department, Premier Jatinegara Hospital, Jakarta, Indonesia
• Clinical Pathologist at Westerindo Private Clinical Laboratory, Jakarta, Indonesia
• Chairman of Indonesian Association for Clinical Chemistry (IACC) 2019-2025
• Board of Executive, Indonesian Association of Clinical Laboratory 2019-2022
• Member of Indonesian Association of Clinical Pathologist External Quality Control Scheme Committee 2019-2022
• Member of Indonesian Association for Clinical Pathologist
• Assessor for ISO 15189 - Indonesian Accreditation Committee
• Assessor for ISO 17043 – Indonesian Accreditation Committee

Dr. Purvi Purohit

Prof (Dr) Purvi Purohit (PhD Biochemistry) is Professor in the Dept of Biochemistry, All India Institute of Medical Sciences Jodhpur. Her research interests are clinical and molecular basis of Diabetes Mellitus, Metabolic Syndrome, Breast Cancer, thanatochemistry, and molecular psychiatry.

She is the recipient of Global Investigator Award 2021 (KSCC), ICMR travel fellowship (2018), IFCC -Roche fellowship (2017), and NIMS-ACBICON Award 2014. She is the corresponding member of IFCC-C-CMBC for ACBI, Academic editor of PLOSone, and Review editor Frontiers Oncology-Breast Cancer.

She is an expert member of the ICMR-NCD Project review committee (Discovery division), Union Public Service Commission subject expert, and Fellow of the Royal Society of Biology.

She has published more than 69 original research articles in various peer-reviewed international and national journals. She is the author of two books and five book chapters on molecular medicine and precision medicine in cancer.

She has received funding from ICMR, DHR, DBT, and RSSDI. Currently, she is working on tumour micro-environment immune modulation in Breast cancer, immune modulation in diabetes mellitus and its complications, biomarker discovery in MDD, toxicologic effects of Bisphenols in NCDs, and determination of time since death in human cadavers using autophagy proteins.

Dr. Jatinder K. Lamba

Dr. Lamba is the Associate Dean for Research and Graduate Education, Professor, and Frank A. Duckworth Eminent Scholar Chair at the University of Florida. Her research focuses on Acute Myeloid Leukemia (AML), a devastating disease with dismal outcomes, and utilizes systems biology-based multi-omic approaches to establish diagnostic and prognostic factors of clinical utility in AML.

Dr. Lamba employs bioinformatics and machine learning approaches across multiple omics factors (genomics, epigenomics, transcriptomics, proteomics, and metabolomics) to define markers of prognostic and therapeutic relevance in AML. This research aims to develop prognostic scores that identify patients at higher risk of disease resistance/relapse, establish pathways of drug-resistance, and identify agents with the potential to overcome resistance to standard chemotherapy.

Dr. Lamba has secured over $11 million in research funding from the NCI and other foundations such as the Leukemia Lymphoma Society, American Cancer Society, St. Baldrick’s Foundation, and the Live Like Bella Foundation. Notable discoveries from her group include CD33 polymorphisms of significant clinical relevance to gemtuzumab response (JCO, 2017) and a pharmacogenetics-based polygenic score that provides prognostic significance and suggests alternative treatment strategies (JCO, 2022).

To pursue this translational research, Dr. Lamba has built a strong team of clinical investigators across multiple institutes, allowing trainees to gain skills at multiple levels. She is actively involved in teaching and mentoring trainees, including postdoctoral and Hem/Onc fellows and graduate students. Several of her trainees have been successfully recruited into academia, industry, and the NCI.

Dr. Tony C Badrick

Tony Badrick AM, BAppSc, BSc, BA, M Lit St (Math), MBA, PhD (QUT), PhD (UQ), FAIMS, FAACB, FACB, FAIM, Member Aust Maths Soc, FRCPA (Hon), FFSc(RCPA), GAICD.

He is the CEO of the Royal College of Pathologists of Australasia Quality Assurance Programs; Adjunct Professor at the School of Pharmacy and Pharmacology, Griffith University, Honorary Associate Professor at the National Centre for Epidemiology and Public Health ANU College of Health and Medicine and ANU College of Science, Honorary Associate Professor, Faculty of Medicine, Bond University, Gold Coast, Visiting Fellow, Australian Institute for Health Innovation, Macquarie University. He is president of the Asian Pacific Federation of Clinical Biochemistry and Laboratory Medicine, a member of the Executive Board of the International Federation of Clinical Chemistry, and the Chief Examiner of the Faculty of Science of the Royal College of Pathologists of Australasia.

Dr. Anjali Manocha

Dr. Anjali Manocha is Vice Chairperson and Senior Consultant in the Department of Biochemistry, Sir Ganga Ram Hospital, New Delhi and Professor in the Ganga Ram Institute of Post Graduate Medical Institute and Research (GRIPMER). She did her MBBS, MD (Biochemistry) and Senior Residency from Lady Hardinge Medical College, New Delhi.

Dr. Anjali Manocha has published many papers in national and international journals as well as chapters in various books. Dr. Manocha has research experience in Basic and Clinical Biochemistry, especially in Lipids and Cardiovascular Diseases and has been a Principal and Co-Investigator in many intra and extra mural projects. She is actively involved in academics and is co-guide for numerous DNB thesis. Dr. Anjali is a Lead Assessor for NABL as well as an Assessor for Entry level NABH and PT providers. In 2013, she was awarded the GRIPMER gold medal for best paper published from Sir Ganga Ram Hospital.

In 2023, Dr. Anjali was awarded Fellow of the Association of the Clinical Biochemists of India in recognition for her outstanding contribution to the Science and Practice of Clinical Biochemistry.

Dr. TESTER FRAMROZE ASHAVAID

Dr. T. F. Ashavaid, Ph.D., L.L.B., FADLM, CSci, FACBI

Profile

Dr. Tester F. Ashavaid has more than 37 years of experience in teaching Clinical Biochemistry and Laboratory Management. She has authored over 250 research publications in various prestigious journals and has interests in:

• Diabetes
• Metabolic Syndrome
• Atherosclerosis
• Antioxidants
• Pharmacogenetics
• Therapeutic Drug Monitoring
• Clinical Toxicology

Dr. Ashavaid has served as a member of the Accreditation Committee of the National Accreditation Board for Testing and Calibration Laboratories (NABL) and was awarded the College of American Pathologists (CAP) Inspector certificate in December 2011.

She is a recognized guide for M.Sc. and Ph.D. candidates affiliated with the University of Mumbai.

Dr. Ashavaid actively participated in the IFCC ‘Worldwide Multicenter Study on Reference Values,’ involving various laboratories from different parts of the world from 2012 to 2016.

In February 2017, she was awarded the Indo-South African grant titled “Therapeutic Outcomes with Second-line Drug Exposures in a Cohort of South African and Indian Patients with Drug Resistant TB: A Pharmacokinetic-Pharmacodynamic Assessment” by DST, DBT. She is also the Principal Investigator for an NIH-funded R01 study entitled “Baseline Prescription According to Direct from Sputum Sequencing and Targeted Drug Concentration Strategy (BRASS Tacs)” - 2024.

Dr. Ashavaid is an active member of the Indian Scientific Advisory Committee of the Lady Tata Memorial Trust, Mumbai.

Since 2018, she has been appointed as the National Lead Investigator for Familial Hypercholesterolemia (FH) for India among 75 countries and is a member of the European Atherosclerosis Society Familial Hypercholesterolemia Studies Collaboration (EAS FHSC) Steering Committee.

Currently, she is associated with more than 20 national and internationally funded research projects.

Presently, she serves as the Consultant Biochemist, Chief of Labs in the Department of Laboratory Medicine, and Director of Lab Research at P.D. Hinduja National Hospital and Medical Research Centre, Mumbai, India.

Dr. Mohammad Kaleem Ahmad

Dr. Mohammad Kaleem Ahmad has made pioneering contributions in the area of natural products, Free Radical Biology, and Molecular Biology. He has explored the role of microRNA in prostate cancer and found some remarkable results suggesting that miRNAs may be used as diagnostic and prognostic biomarkers in prostate cancer. He has published 96 research articles in reputed international journals, with citations exceeding 2500.

Achievements

• Awards: 30
• Publications: 96
• Citations: >2500
• h-index: 26
• i10-index: 53
• Book chapters: 07
• Projects: 14 (As Principal I./Mentor); 11 (As Co-Investigator)
• Ph.D. Thesis: 09 (As Supervisor); >20 (As Co-Supervisor)
• Invited Talk Presentations: 19
• Conference Organized: 15
• Conference Attended: >50

Dr. Amit Awasthi

Dr. Amit Awasthi, currently heading the Immunobiology/Immunology Core laboratory, is a Professor at THSTI, Faridabad. He is an internationally renowned immunologist with significant research contributions in the field of T cell biology in inflammatory and infectious diseases. He has published over 100 publications, including several seminal papers in prestigious international journals such as Nature, Nature Immunology, Nature Communications, Science Advances, and Lancet Infectious Diseases, with an h-index of 39 and over 14,000 citations.

He has been conferred with many prestigious awards including the ‘Innovative Young Biotechnologist Award’ and ‘GN Ramachandran National Bioscience Award’ presented by the Department of Biotechnology, the ‘CDRI Award’ for excellence in Drug Discovery research presented by CSIR-Central Drug Research Institute, the ‘GP Talwar Mid Career Award’ by the Indian Immunology Society, and the ‘Young Scientist Platinum Jubilee Award’ by the National Academy of Sciences of India. He is the Secretary-General of the Indian Immunology Society, a founding member of the Immune-Oncology Society of India, and an Executive Council Member of the Federation of Immunological Societies of Asia-Oceania (FIMSA).

Amit has been working at THSTI since 2012 in the field of T cell biology in inflammatory diseases, including bowel disease (IBD). He secured the prestigious India-Alliance intermediate fellowship. Amit has significantly contributed to understanding the biology of IL-9-producing helper T cell subsets (Th9) in tissue inflammation of autoimmune diseases, allergic inflammation, and extracellular infections. His seminal work in discovering and identifying the transcriptional landscape of Th9 cells has been well recognized globally.

Amit has shown that ATP triggers Th9 cell differentiation via the mTOR-HIF1-a axis. Th9 cells have been shown to be crucial in inducing anti-tumor functions. His recent work identified that Areg-EGFR activation-induced HIF-1 alpha is essential for the generation and functions of Th9 cells. He has also identified that Foxo1 is essential for Th9 cell differentiation and functions, demonstrating that the Foxo1-IL-9 axis is critical in inducing immunopathologies in respiratory illnesses like COVID-19.

Dr. Subash Chandra Gupta

Dr. Subash Chandra Gupta is a Professor and Head at the Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Guwahati. He also holds the position of Associate Dean (Research) at AIIMS Guwahati. Dr. Gupta and his team have developed a diagnostic facility that caters to the needs of biochemical investigations for patient care at AIIMS Guwahati.

He has contributed significantly to understanding the role of inflammatory pathways in cancer pathogenesis. His current research focuses on uncovering the mechanisms by which acidic microenvironments contribute to the pathogenesis of cancer types such as breast cancer, head-and-neck cancer, gallbladder cancer, and glioblastoma. His laboratory is also working on cancer chemoprevention and other projects to understand the role of cancer stem cells, exosomal microRNAs, and long non-coding RNAs in regulating tumor development.

He has published 122 peer-reviewed articles in highly prestigious journals and has written several book chapters. His work has been cited by numerous prestigious, peer-reviewed international journals (total citations: > 29,400; h-index: 67; i10-index: 115). He has been honored with prestigious national and international awards, co-edited special issues of scientific journals, and four prestigious books.

Currently, he is an editorial board member of several scientific journals and an active reviewer for more than 80 journals. He has been actively involved in teaching undergraduate and postgraduate students and has been supervising master's and doctoral candidates.

Dr. Sadhana Joshi

Dr. Sadhana Joshi completed her PhD in Nutritional Biochemistry from Agharkar Research Institute, Pune, India. She joined Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth University, Pune, as a Senior Scientist in 2004. Currently, she heads the Division of Mother and Child Health at IRSHA and has been working in this area for over 30 years.

Maternal nutrition and early life events are now recognized to play a vital role in the development of non-communicable diseases later in life. Her work has resulted in several novel findings, published in over 160 international journals. The group has received numerous grants from various departments of the Government of India, including DBT, ICMR, and DST, along with several student projects funded by these organizations.

Due to her commendable work in biomedical research, BVDU-IRSHA is now recognized as an ICMR Collaborating Centre of Excellence. She served as the Principal Investigator for the Centre for Advanced Research at IRSHA from 2017 to 2022. Dr. Joshi is a recipient of the 9th Dr. Rajammal P. Devadas Memorial Award at the 50th Annual International Conference of the Nutrition Society of India, as well as the Research Excellence Award for Developing Country Scientists at the 7th World Congress on Developmental Origins of Health and Disease in Portland, USA. She also received the “Best Researcher Award” at the 15th Foundation Day Ceremony at Bharati Vidyapeeth University, Pune.

Her group has received numerous awards and honors at various Nutrition Society of India meetings. Dr. Joshi is an Editorial Board member of the “Journal of Nutrition & Intermediary Metabolism” (ELSEVIER) and a reviewer for various high-impact international journals. She is involved in several task forces and committees, including the DBT and the Expert Committee on Wellness Counselling formed by the State Project Director of Rashtriya Uchchatar Shiksha Abhiyan (RUSA), Maharashtra.

Dr. Joshi has also participated in prestigious events such as the 2016 Grand Challenges Meeting sponsored by the Bill & Melinda Gates Foundation in London and delivered talks at the Indian Science Congress and various international conferences. Over 25 students have obtained their PhD degrees under her guidance, and she remains actively involved in mentoring current PhD candidates.

She is a member of several professional organizations and has made significant contributions to the field of applied biotechnologies and maternal health.

Dr. Sandeep Saxena

Prof. School of Biotechnology, JNU. Previously Scientist , National Institute of Immunology

Dr. B S S Rao

Dr. B S S Rao is a Professor and Head of the Department of Neurophysiology at the National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, and an Adjunct Visiting Professor at Kasturba Medical College, Manipal University. His research areas include cellular and molecular mechanisms of learning and memory, stress and cognitive deficits, and drug discovery for neuropsychiatric disorders.

With over 225 publications in high-impact journals and numerous awards, including being a Fellow of several prestigious academies, Dr. Rao has made significant contributions to understanding brain mechanisms and developing therapeutic drugs.

Dr. Anibh Martin Das

Anibh Martin Das is the head of Paediatric Metabolic Medicine at the Department of Paediatrics, Hannover Medical School. He has a rich academic background, having studied medicine at Göttingen University and conducted research under the Max-Planck Society in respiratory physiology.

With a postdoctoral fellowship at the University of Oxford focusing on cardiac energy metabolism, Dr. Das specializes in Inborn Errors of Metabolism and Neuropaediatrics, concentrating on energy and amino acid metabolism as well as lysosomal storage diseases. He is also involved in Newborn screening at the Screening Laboratory Hannover and serves on various scientific advisory boards.

Dr. Shantanu Sengupta

Shantanu Sengupta is the Chief Scientist at the CSIR-Institute of Genomics and Integrative Biology, Delhi. His research focuses on Clinical Proteomics and Metabolomics. After completing his Masters in Organic Chemistry from Jadavpur University, he earned his PhD from the CSIR - Indian Institute of Chemical Biology.

Following his postdoctoral work at the National Institute of Immunology, New Delhi, and the Cleveland Clinic Foundation, Ohio, USA, he is now investigating the genetic, proteomic, and metabolomic bases of cardiovascular diseases. His notable research has demonstrated a significant association between vitamin B12 deficiency and coronary artery disease (CAD) in India.

Dr. Sengupta has established the proteomics and metabolomics facility at IGIB, focusing on identifying biomarkers for CAD and other cardiovascular disorders. He serves as the President of the Proteomics Society, India, and holds positions in several international organizations. He has published extensively in reputed journals and is an Academic Editor of the Journal of Proteins and Proteomics. In recognition of his contributions, he received the DBT Biosciences Award in 2011 and is a fellow of the National Academy of Sciences (NASI) and the West Bengal Academy of Science and Technology.

Dr. Shivani Pandey

Professor in the Department of Biochemistry at King George’s Medical University, Lucknow, U.P., India, Dr. Shivani Pandey has 26 years of teaching and research experience. She holds a mobile contact of +91-9415015122 and can be reached via email at drshivani111263@gmail.com.

Dr. Pandey's achievements include:

• Awards: 10
• Publications: 89
• Book Chapters: 10
• Projects: 12 (Principal Investigator), 8 (Co-Investigator)
• Patent Filed: 1
• Research Awards: 5

She is a life member of several prestigious societies, including:

• RSSDI
• Indian Academy of Neurosciences
• Association of Clinical Biochemistry of India
• Society for Free Radical Research of India
• U.P Association for the Science & Technology Advancement
• Indian Society for Lead Awareness & Research

Dr. Pandey has received fellowships from:

• National Academy of Medical Sciences
• International Society of Medicinal Food and Nutrition
• Indian Society of Chronomedicine
• Indian Association of Biological Science
• Honorary Fellowship Society of Applied Science

Dr. Sohini Sengupta

Dr. Sohini Sengupta holds an MD and DNB in Clinical Biochemistry, along with an FNB in Laboratory Medicine. Currently, she serves as the Director of Lab (NRL) and Head of Clinical Biochemistry at Healthians Labs, India.

She has previously worked at Sir Gangaram Hospital, MAX Healthcare, and Redcliffe Labs. In addition to her clinical roles, she is a Technical Assessor for NABL and holds a Green Belt in Six Sigma processes.

Dr. Sengupta represents India on the IFCC-POCT Committee and the IFCC Working Group on Laboratory Errors & Patient Safety. Her key areas of interest include:

• Maternal and Reproductive Health
• Point of Care Testing
• Quality Assurance in Clinical Laboratories

She is a reviewer for the Indian Journal of Clinical Biochemistry and has published research in various indexed national and international journals.

Dr. Rajarshi Kar

Dr. Rajarshi Kar is a distinguished professor at UCMS, Delhi, with a strong academic background and extensive research experience. He earned his MBBS from R G Kar Medical College, Kolkata, in 2000, followed by an MD in Biochemistry from AIIMS, New Delhi, in 2007.

His research interests encompass cancer, molecular biology, metabolic diseases, and environmental pollutants. Dr. Kar has published over 50 research papers in prestigious international journals and is an active member of the American Association for Cancer Research (AACR) and the Indian Association for Cancer Research (IACR).

His significant contributions to cancer research have been recognized with awards from the AACR and the National Institute of Health, USA.

Dr. Kandimalla Ramesh

Dr. Kandimalla Ramesh has been the principal investigator for multiple research grants, including NIH and DBT-funded projects. He also serves as an editorial board member for esteemed journals such as *Brain Research* and *Frontiers in Aging Neuroscience*.

Selected Honors

• World Top 2% Scientist in Neurology (2021-2024)
• Best Poster Award, Texas Tech University (2016)
• DBT-Ramalingaswami Fellowship (2017)

Dr. Navneet Agnihotri

Position: Professor, Department of Biochemistry, Panjab University, Chandigarh.

Area of Research: Cancer Biology
Major Area: Lipid Metabolic Reprogramming and Cancer Biology.

Dr. Navneet Dhillon

Navneet Kaur Dhillon, Ph.D., is a distinguished tenured professor in the Pulmonary and Critical Care Division at the University of Kansas Medical Center. Her academic journey began with a B.S. and M.S. in Biochemistry from Panjab University, India, followed by a Ph.D. in Biochemistry from the Postgraduate Institute of Medical Education and Research, Chandigarh, India. Dr. Dhillon's research focuses on understanding the pathogenesis of infection-related cardiopulmonary diseases, especially pulmonary hypertension. Her laboratory explores the synergistic effects of HIV proteins and illicit drugs on pulmonary endothelial dysfunction, aiming to unravel the mechanisms driving these complications. Dr. Dhillon has published extensively her work on the involvement of extracellular vesicles in mediating vascular dysfunction in patients with COVID-19 and HIV-1 is widely recognized and quoted worldwide. She has been successful in securing multiple NIH and foundation grants and at one time had three NIH R01 awards to pursue these studies.
Dr. Dhillon holds numerous leadership roles, including Director of Pulmonary Research and Director of the Parker B. Francis Summer Fellowship Program. She is also the current president of the Infection and Pulmonary Vascular Disease Consortium (iPVDc). Over her career, she has received several prestigious awards, including the Outstanding Research Investigator Award and Noffsinger Investigator Award at her Institute, Parker B. Francis Speaker Award at the American Thoracic Society International meeting, the Junior Scientist Award from the Association of Scientists of Indian Origin in America, and the Young Investigator Award at the Conference on Retroviruses and Opportunistic Infections. In addition, she serves on several national and international study sections and is a reviewer for high-impact journals. Dr. Dhillon continues to mentor early-career investigators and leads initiatives that promote multidisciplinary collaborations aimed at addressing infection-associated cardio-pulmonary diseases.

Dr. Priyanka Srivastava

Dr. Priyanka Srivastava has done her PhD in Genetics. Presently, she is working as an Assistant Professor at Genetic Metabolic Unit, Department of Paediatrics, PGIMER, Chandigarh. Her research is primarily dedicated to Advanced Human Molecular Genetics, Cytogenetics, Next Generation Sequencing, Microarray, Fetal and Reproductive Genetic

Dr. Neeraj Jain

Position: President & Course Director, MELAP, New Delhi

Qualifications: MBBS, MD (Path)

Training Participation:
- Participated in a 3-day training on APAC Fundamentals for Trainers and Training Course Delivery from 2-4 Aug 2022 organized by APAC (Asia Pacific Accreditation Cooperation).

- Participated in a 3-day training on Accreditation of Medical Testing (ISO 15189:2022) and Point-of-Care Testing (POCT) from 31 Jan - 02 Feb 2023 organized by APAC (Asia Pacific Accreditation Cooperation).

Dr. Indu Pal Kaur

Position: Professor of Pharmaceutics, UIPS and DPIIT-IPR Chair Professor, Panjab University.

Dr. Kaur is listed amongst the top 2% most cited scientists globally since 2019, with 170 published papers (h-index of 55). Her research focuses on enhancing the bioperformance of drugs, plant extracts/phytochemicals, and biomolecules using active-tailored nanocarriers. The translational value of her work is evident in the licensing of 4 technologies to industry, along with 21 granted and 14 filed patent applications.

Achievements:
- WIPO Medal for Inventors (2023)
- Best Pharmaceutical Scientist (Association of Pharmacy Teachers of India, 2023 & Organisation of Pharmaceutical Producers of India, 2018)
- National Intellectual Property Award (2021 and 2022) for highest patents filed, granted & commercialized
- Grand Innovation Challenge award by Indian Pharmaceutical Alliance (2021)
- Two-time Technology Award (BIRAC 2019 and 2020)
- US-Fulbright Fellow (2017-18)
- Beamtime at RAL Laboratory, UK (2017; 2023)
- Funding of around 940 lac INR from Government and Industry.

Dr. Uma Kanga

Position: Additional Professor, Dept of Transplant Immunology and Immunogenetics, AIIMS, New Delhi.

Research Focus: Genetic profiling of the Indian population, understanding the molecular basis of disease susceptibility, and transplant monitoring. Dr. Kanga has almost 100 publications to her credit.

Her research work has been awarded by The European Federation of Immunogenetics and The Transplantation Society. With her vast experience in Transplant Immunology, her laboratory supports the Organ and Stem Cell Transplant program for donor selection and monitoring of outcomes.

In 2021, the European Board of Surgery conferred upon her the title of 'Fellow in Transplantation Immunology'. She is also a recipient of the prestigious Commonwealth Fellowship and is a fellow of the Japanese Society for Promotion of Science.

Dr. Kanga is an elected member of the International HLA and Immunogenetics Council and serves in several scientific organizations as Vice President, Councilor, Treasurer, and Secretary. Additionally, she is a member of the General Assembly and Gender Equity Committee of the International Union of Immunological Societies.

Dr. Vinod Scaria

Background: Dr. Vinod Scaria is a clinician turned computational biologist. His research interests focus on understanding the function, organization, and regulation of vertebrate genomes and how genomic variations may impact them. He is a co-founder of the Genomics for Understanding Rare Disease: India Alliance Network (GUaRDIAN), one of the largest networks of clinicians and researchers in India working on rare genetic diseases.

His research has contributed to numerous insights and technologies widely used in India for the diagnosis and screening of genetic diseases. Dr. Scaria has participated in collaborative genomics projects aimed at understanding Indian and Asian genome diversity, including early whole genome sequencing population genomics projects in India, Sri Lanka, and Malaysia. He is also a member of the HUGO PanAsian Population Genomics Initiative (HUGO-PAPGI) task force and has established one of the earliest fellowship and education programs in genomics for clinicians in India.

Education: Dr. Scaria completed his undergraduate medical education at Calicut Medical College, University of Calicut, and earned his PhD in Computational Biology from the University of Pune.

He has over 200 research publications in international peer-reviewed journals and has authored two books. Additionally, he serves on the editorial boards of several journals, including PLoS ONE, Translational Genomics, Journal of Orthopaedics (Elsevier), PeerJ, and the International Journal of Rheumatic Diseases (Wiley).

Awards: Dr. Scaria is the recipient of the CSIR Young Scientist Award for Biological Sciences in 2012, a Kavli Frontiers of Science Fellow of the US National Academy of Sciences in 2015, and an elected Fellow of the Royal Society of Biology (2017) and the Royal Society of Public Health (2022).

Dr. Poornima Manjrekar

Degree	Year of Passing	Institution	University
MBBS	1999	KIMS, Hubli	Karnataka University Dharwad
MD (Biochem)	2002	KMC Mangalore	MAHE, MANIPAL
PhD	2013	KMC Mangalore	Manipal University

Teaching Experience

• Tutor in Biochemistry - August 1999 to August 2002
• Assistant Professor - August 2002 to December 2007
• Associate - December 2007 to February 2011
• Professor & H.O.D. in Biochemistry at Kasturba Medical College, Mangalore - February 2011 to February 2018
• Currently - Professor of Biochemistry since February 2018

Responsibilities

• Research Convenor, KMC, Mangalore
• Coordinator - MSc. Medical courses, KMC Mangalore
• Recognised PhD Guide – Manipal Academy of Higher Education, Manipal
• Convener – Faculty Research Forum, KMC Mangalore
• Coordinator – Central Research Laboratory, KMC Mangalore
• Advisor – Faculty research vertical and Doctoral research vertical
• Chairperson – Institutional Scientific Committee - 3
• Member, Composite Research Committee of the institution
• Co-Chairperson – Central Scientific Committee, NITTE University
• Member – PG and Research Board at Yenepoya University

Conferences/Workshops/CME

Attended and presented – About 60 CMEs, workshops & conferences

Conducted – 11 CMEs, 1 Regional Conference, and 43rd National Conference of Association of Clinical Biochemists of India

Past President – Association of Clinical Biochemists of India (President ACBI – 2017)

Recipient of – Fellow of the Association of Clinical Biochemists of India (FACBI)

Secretary – Association of Medical Biochemists - Karnataka Chapter

Secretary AMBKC – 2019 onwards

Publications

More than 100 publications in National and International Journals

Peer Reviewer for several National and International journals

Membership of Professional Bodies

• Life member Association of Clinical Biochemists of India – ACBI
• Life member Association of Medical Biochemists of India - AMBI
• Life member Association of Medical Biochemists – Karnataka Chapter - AMBKC
• Life member Research Society for the Study of Diabetes in India - RSSDI
• Life member Society of Biological Chemists - SBC

Research Areas

• Diabetes and its complications
• Metabolic Syndrome
• Thyroid Disorders
• Obesity

Contact Information

Email: poornima.manjrekar@manipal.edu
Alternate Email: drpamanjrekar@gmail.com
Phone: +91 94490 33990

Dr. Binita Goswami

MD; DNB; MNAMS; FIMSA; FAIMER (CMCL) Professor Department of Biochemistry Maulana Azad Medical College, Delhi

Dr. Goswami completed her undergraduate (2001) and postgraduate (2005) education at the prestigious Maulana Azad Medical College, Delhi University. She has held faculty positions at various reputed institutes, including GB Pant and LHMC. As an external examiner, she has contributed to multiple universities and is on the expert panel of the National Board of Examinations and UPSC. Dr. Goswami serves as the Associate Editor of the *Indian Journal of Medical Biochemistry* and has published over 150 research papers in national and international journals.

Her key areas of interest include molecular diagnostics and medical education. She has supervised numerous intramural and extramural research projects and reviews for several prestigious journals such as CVJSA, CCA, IJEM, IJMB, and Clinical Biochemistry.

Teaching Experience

Designation	Institution	From	To	Duration
Senior Resident (Post MD)	Maulana Azad Medical College, Delhi	2005	2008	3 years
Assistant Professor	GB Pant Hospital, Delhi	2008	2011	2 years 9 months
Assistant Professor	Lady Hardinge Medical College, Delhi	Aug 2011	Aug 2013	2 years
Associate Professor	Lady Hardinge Medical College, Delhi	Aug 2013	Jan 2017	3 years 4 months
Associate Professor	Maulana Azad Medical College, Delhi	Jan 2017	Aug 2017	8 months
Professor	Maulana Azad Medical College, Delhi	Aug 2017	Till date	7 years

Total teaching experience: more than 19 years after obtaining postgraduate degree.

Dr. Ravinder Singh

With 25 years of experience in laboratory medicine, primarily at the renowned Mayo Clinic, Dr. Ravinder Singh has established a deep expertise in laboratory diagnostics, focusing on point-of-care testing (POCT) and endocrinology. His contributions are underscored by numerous publications, which have received substantial citations, reflecting the significant impact of his research on clinical practice and academic discourse.

At the Mayo Clinic, Ravinder has been involved in pioneering innovative testing methods that enhance the accuracy and efficiency of patient diagnoses. His focus on POCT demonstrates his commitment to improving accessibility and responsiveness in healthcare settings, facilitating quicker decision-making in critical situations. In endocrinology, his work encompasses a wide range of topics, from hormone testing to the management of metabolic disorders, providing valuable insights into the understanding and treatment of endocrine diseases.

Ravinder's dedication to research and education in lab medicine highlights his role as a practitioner and a mentor and leader in the field. His ongoing efforts to publish and share findings serve to advance knowledge and best practices, benefiting both current and future healthcare professionals.

Dr. Adil I. Khan

Adil I. Khan, MSc, PhD, is a Professor of Pathology at Temple University, Philadelphia, and serves as the Medical Director for Point-of-Care Testing & Clinical Chemistry Laboratories for the Temple University Health System. His research focuses on understanding the role of adhesion molecules and extracellular vesicles in inflammation, including those associated with SARS-CoV-2.

On the clinical side, Dr. Khan is actively involved in clinical trials of point-of-care testing devices and laboratory instruments, as well as assay development. He is a member of the Canadian Society of Clinical Chemists (CSCC) and the Association for Diagnostic and Laboratory Medicine (ADLM).

Previously, he served as treasurer and chair of the Philadelphia section of the ADLM, and currently holds positions such as Chair of the Nominating Committee of the Critical and Point-of-Care Testing Division, as well as Chair of the IFCC Committee on Point-of-Care Testing.

Dr. Abid Hamid Dar

Present Positions:

• Dean, School of Life Sciences; Central University of Kashmir.
• Director, Science Campus, Ganderbal; Central University of Kashmir.
• Head, Department of Biotechnology, School of Life Sciences; Central University of Kashmir.

Educational/Research Qualification:

• Faculty (on Deputation) at University of Wisconsin-Madison, WI, USA.
• Postdoctoral Research from University of Pittsburgh Cancer Institute, NCI, USA.
• Ph.D. (Biochemistry) from PGIMER, Chandigarh in December, 2006.
• M.Sc. (Biochemistry) from University of Kashmir in May, 2001.

Research Interests:

• Cancer Epigenetics & Novel Therapeutic Targets
• Cancer Cell Signaling & Target Based Inhibitors for Drug Discovery
• Stem Cell Biology, Epigenetics & Tissue Recombination Models in Cancer
• Molecular Membrane Biochemistry & Cellular Biology
• Nutrigenomics and Cancer

International/National Level Distinctions (Awards, Fellowships, Academic Honors, Nominations & Scholarships):

• Published work has received approx. 4208 citations (h-index=41 & i10-index=92) till date.
• Awarded Indo-US Research Fellowship by Indo-US, S & T Forum in 2012.
• Awarded Young Scientist Award from State, Science & Technology for 2012.
• Awarded BOYSCAST Fellowship for Research in USA by DST, India in 2011.
• Awarded DST Fast Track Grant for Young Scientists in 2011.
• UPSC Nominated Subject Expert/Advisor for Interviews/Personality Test Boards by Union Public Service Commission, Govt. of India.
• Nominated as “Bentham Ambassador” for India in 2017.
• Awarded AACR-2015 Travel Grant Award (Biotechne).

Professional Research/Teaching Experience and Training (21.5 years):

• Academic Supervision: 14 PhD Awarded
• Initiatives for Skill, Innovation, Startup & Entrepreneurship at Central University of Kashmir.
• Teaching Experience: 21.5 Years
• Invited Talks: 25
• Invited Review Articles: 13
• Publications: 115
• International Patents Filed/Granted: 7
• Books (Sole author) Published: 2
• Book Chapters Published: 3
• Extramural Grants as Principal Investigator: Completed: 11; Ongoing: 5
• Member of Journal Editorial Advisory Board: 11 Journals
• Reviewing Expertise in International Peer-Reviewed Journals: 60 Journals
• Reviewer of Extramural Grants from National Funding Agencies
• International & National Research Collaborations
• Administrative & Academic Experience: 15 Years

Dr. Archna Singh

I am a medical graduate with a PhD and a Master’s in Public Health Nutrition with over 15 years of post-PhD research experience. I have nearly 60 publications in indexed journals encompassing the breadth of my research. I have mentored four PhDs, 10 postgraduate students, and two post-doctoral fellows.

The broad research focus of my laboratory is lipid metabolism in cancer, CAD, and obesity. Our cancer research analyzes various aspects of mtDNA regulation and metabolic reprogramming in pediatric B-ALL. We also work on HDL function and quality in relation to its key physiological functions and explore the role of a component of the reverse cholesterol pathway, i.e., ABCA1, in maintaining adipocyte homeostasis in obesity.

We also have a public health nutrition component in our research, related to food systems sustainability and the nutritional status of indigenous tribal communities of India. I am a collaborator on a recently awarded Team Science Grant to develop cost-effective and feasible diagnostic technologies for micronutrient assessment among remote, vulnerable communities. We are also interested in understanding the effect of various dietary components on inflammatory biomarkers among CAD patients.

Dr. Archana Singh

I did my MBBS and MD Biochemistry from Maulana Azad Medical College, Delhi and Lady Hardinge Medical College, Delhi respectively and worked as faculty at dept of Biochemistry, University College of Medical Sciences, Delhi. During this time I worked in various aspects of women health, to understand mainly genetic and Immunological aspect of pre-eclampsia and intra uterine growth restriction. I am currently working at dept of Biochemistry at AIIMS, Delhi since last ten years. My main area of interest in research is TB Immunology focusing on Biochemical, Genetic and Immunological host factors of Tuberculosis pathophysiology with a special focus on household contacts of TB patients. My laboratory is also involved in development of new adjuvant therapy in treatment of pulmonary TB. I have published more than 45 research articles in reputed Journals as corresponding author and Co-author and have received various national and international awards for our research work. I have received AIIMS Excellence Research Award twice in 2019 and 2022 for our work published in scientific reports and European Journal of immunology. I am carrying out TB research work with the help of various extramural grants (SERB, ICMR, TB Association of India) and AIIMS intramural grants with my team comprising our collaborators and especially my students comprising of PhDs, MDs, MSc and MBBS students.

Dr. Arindam Maitra

Arindam Maitra is the Associate Director and a Professor at BRIC-National Institute of Biomedical Genomics, Kalyani, India. He graduated from All India Institute of Medical Sciences, New Delhi. He is also an Adjunct Professor at BRIC-Regional Centre for Biotechnology, Faridabad, and a Fellow of the West Bengal Academy of Science and Technology.

Dr. Barnali Das

Dr. Barnali Das, MD, DNB, PGDHHM, FADLM, is the Lead Consultant for Biochemistry, Immunology & Toxicology at Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute, Mumbai, India. She is also the Chair of ADLM (formerly AACC), India Section.

She serves as a College of American Pathologist (CAP) Inspector and has been part of the Executive Committee of the IFCC Scientific Division from 2018-2023, currently associated with IFCC C-RIDL. She is on the Advisory Board & Core Committee of the ICMR Task Force for Reference Interval in the Indian Population and is an Editorial Board Member for many journals.

Dr. Das has received 3 orations and numerous awards, including 5 international and 11 national awards such as the College of American Pathologist (CAP) Inspector Excellence Award, AACC (now ADLM) Outstanding Speaker Award, Reliance CSR ‘The Woman of Substance Award,’ ‘The White Knight Award,’ and the Global Investigation Award. She was featured in the 2023 Power List of “The Pathologist” and is a Fellow of the Association for Diagnostics & Laboratory Medicine (formerly American Association of Clinical Chemistry).

Dr. Bela Goyal

Dr. Bela Goyal is currently working as an Additional Professor in the Department of Biochemistry at AIIMS Rishikesh. With over 12 years of experience in teaching, research, and clinical lab work at premier medical institutions such as PGIMER Chandigarh, GMCH Chandigarh, and AIIMS Rishikesh, she has established herself in the field of biochemistry.

Currently, Dr. Goyal serves as the In-charge of the Departmental Onco-biochemistry Lab and is an active core committee member of the Institutional Research Cell. Her primary research interests lie in cancer diagnostics, with a focus on gastrointestinal malignancies and head and neck cancers.

Dr. Goyal has an impressive publication record, having authored around 40 peer-reviewed articles in both national and international journals. She earned her MD in Biochemistry from PGIMER Chandigarh and has received extensive training in molecular techniques from PGIMER Chandigarh and AIIMS Delhi.

She is a member of various national and international professional bodies, reflecting her commitment to staying at the forefront of her field. Throughout her career, Dr. Goyal has been involved in 26 research projects as either the principal or co-investigator, securing funding from both institutional and national agencies. Her contributions to the medical community have been recognized with several prestigious awards, including gold medals for academic excellence during her MBBS, as well as Teacher's Day and Research Day awards from her institute. These accolades highlight her dedication to both education and research.

Dr. Goyal's expertise and unwavering commitment to advancing cancer diagnostics make her a valuable asset to the academic and medical research community.

Dr. Binu Kumar

Dr. Binu Kumaris a Principal Scientist at the CSIR-Institute of Genomics & Integrative Biology in New Delhi, India. He also holds the position of Associate Professor at the Faculty of Science, AcSIR, India. Dr. Binukumar earned his Ph.D. in Molecular Neurobiology from the Postgraduate Institute Of Medical Education & Research (PGIMER) in Chandigarh, India. After his doctoral studies, he pursued post-doctoral training in neurology and therapeutics at the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH) in the United States. He further specialized in stem cell biology and neurophysiology through a second post-doctoral position at the National Institute of Child Health and Human Development (NICHD), NIH, Maryland, USA.

In his research laboratory, Dr. Binu focuses on elucidating the intricate pathogenic mechanisms underlying neurological disorders that impact movement, learning, and memory. His team has notably identified a novel kinase inhibitor with potential in mitigating cognitive impairments in a mouse model. Dr. Binukumar has authored numerous publications in prestigious scientific journals, particularly on neurodegenerative disorders such as ALS, Parkinson's disease, and Alzheimer's disease.

Beyond neurodegenerative disorders, Dr. Binu engages in genetic studies on conditions like Wilson's disease and Parkinson's disease. He has initiated the pan-India program "Indian Collaborative Research Network on Wilson's Disease (iCROWD)," aimed at enhancing molecular genetics understanding for better diagnosis and therapy. This program has established a pilot network with over 45 clinicians from 25 centers across India. Dr. Binukumar is also dedicated to modeling genetic disorders using induced pluripotent stem cells (iPSCs) and organoid culture, creating in vitro models that closely replicate the characteristics of genetic disorders for deeper insights and potential therapeutic developments.

**Honors and Awards:**

• “Exceptional Summer Internship Program mentor award” 2016, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), USA.
• Recipient of “Dr. R. Nath Gold Medal” award from PGIMER, Chandigarh for the best published research work in Biomedical sciences during the year 2010-2011.
• Young Scientist award, International Conference on Neuroscience updates & Annual Meeting of Society for Neurochemistry, December 12-14, 2009.

Dr. Binukumar has authored 36 original scientific and medical articles, 6 reviews, and 2 book chapters.

Dr. Bidhan Chandra Koner

Name: Dr. Bidhan Chandra Koner

Education:

• MBBS from NBMC (NBU) in 1988
• MD (Biochemistry) from IMS (BHU) in 1994

Experience:

• Senior Resident at UCMS
• Faculty at BPKIHS & JIPMER
• Current position: Director Professor & Head of Biochemistry at MAMC

Field of Research:

• Pesticide Biochemistry
• Stress Biology
• Clinical Biochemistry
• Medical Education - Teaching-Learning Methodology

Publications:

• Articles published: 125
• H-Index: 33
• Total citations: More than 3500

Dr. Debabrata Dash

• Dr. Dash is a Senior Professor in the Department of Biochemistry, Institute of Medical Sciences, BHU. Apart from MD, he is also a DNB, PhD, and DSc in Biochemistry.

• He has been a Fellow of the following Medical and Science Academies in the country:

• National Academy of Medical Sciences (FAMS)
• Indian National Science Academy (FNA)
• Indian Academy of Sciences (FASc)
• National Academy of Sciences (FNASc)

• In recognition of his research on platelet and thrombosis biology, the Ministry of Science & Technology, Govt of India, has awarded him with Tata Innovation Fellowship (2012) and JC Bose National Fellowship (2018, renewed in 2023).

• Dr. Dash has received several international fellowships, including AMBO Fellowship (Japan), Humboldt Fellowship (Germany), Commonwealth Fellowship (UK), and Overseas Associateship (Harvard Medical School, USA).

• Dr. Dash has been honored with several awards, including:

• OPPI Scientist of the Year Award (2020) by the Organization of Pharmaceutical Producers of India (OPPI)
• ‘Dr. Subba Rao Memorial Award’ (2020) by Indian National Science Academy (INSA)
• National Research Award in Nano Science & Technology (2018) by the Ministry of Science & Technology, Govt. of India
• Biju Patnaik Award for Scientific Excellence (2017) by Odisha Science Academy and Ministry of Science & Technology, Govt. of Odisha
• Sun Pharma Research Award (2017) by Sun Pharma Science Foundation
• Basanti Devi Amir Chand Prize (2016) by ICMR
• Dr. C.N.R. Rao Award for Excellence in Scientific Research (2014) by CNR Rao Education Foundation

• Dr. Dash has 5 patents and 155 research publications in international journals. He has supervised 41 MD and 21 PhD students and has run 36 research projects.

• In recognition of his research, ICMR has upgraded his laboratory to “Centre for Advanced Research on Platelet Signaling and Thrombosis Biology”.

The major research thrust of Dr. D. Dash over the last 35 years has been thrombus biology, molecular mechanisms of platelet activation, and the application of nanotechnology to medicine.

Dr. Dhiraj Kumar

Dr. Dhiraj Kumar is the Group Leader of the Cellular Immunology Group at the International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi.

His research focuses on cellular immunology with an emphasis on understanding the complex mechanisms of immune responses and their implications for health and disease.

Dr. Mingma Lhamu Sherpa

Dr. Mingma Lhamu Sherpa is a Professor and Head of Biochemistry at Sikkim Manipal Institute of Medical Sciences (SMIMS), Sikkim Manipal University (SMU). With over 20 years of experience, Dr. Sherpa has made significant contributions to medical education, research, and clinical biochemistry.

She holds an MBBS (1998) and an MD in Biochemistry (2004) from Lady Hardinge Medical College, Delhi University, India. Her career has been marked by her role in developing and implementing innovative curricula, including the paramedical science course, and the new NMC Competency-Based Curriculum for the MBBS program.

Dr. Sherpa has mentored over 2000 undergraduate students, as well as numerous MSc, MD, and PhD scholars. Her research includes successful completion of over 10 funded research projects, resulting in 22 publications and three book chapters. She is currently involved in the PRESCRIPTEC multicentric multinational project, focusing on biomarker studies in chronic non-communicable diseases.

Her technical expertise includes clinical chemistry, molecular biology, and stem cell culture techniques. Dr. Sherpa established a 24-hour clinical biochemistry laboratory at SMIMS, showcasing her problem-solving and leadership skills. She also managed the Central Referral Hospital in Sikkim from 2015 to 2021, improving finance, quality of care, and patient footfalls.

As Co-Chair of the Staff and Faculty Capacity Building Council since 2021, Dr. Sherpa has facilitated high-impact training for over 200 staff members, enhancing the capacity of SMU.

Dr. Naibedya Chattopadhyay

Dr. Naibedya Chattopadhyay is a Chief Scientist in the Division of Endocrinology at CSIR-Central Drug Research Institute, Lucknow. He is also a Professor of Biological Sciences at the Academy of Scientific and Innovative Research (AcSIR), New Delhi.

At CSIR-Central Drug Research Institute, Dr. Chattopadhyay leads cutting-edge research in endocrinology, focusing on the development of innovative therapeutics. His work involves a multidisciplinary approach to understanding endocrine disorders and finding novel solutions for their management.

As a Professor at AcSIR, he contributes to advancing biological sciences education and research. His academic role includes mentoring students, leading research projects, and collaborating with other experts in the field.

For more information, you can visit his profile on the CSIR-Central Drug Research Institute website: Dr. Naibedya Chattopadhyay's Profile.

Dr. Prateek Bhatia

Dr. Prateek Bhatia is a post-graduate in Pathology and completed his doctorate in Pathology in 2005 from PGIMER, Chandigarh, India. He has been in charge of the Paediatric Hematology Oncology Molecular Laboratory at PGIMER, Chandigarh since 2011.

Dr. Bhatia has published over 130 articles in national and international journals. His research interests include childhood acute leukemias, inherited bone marrow failure syndromes, and paediatric inherited iron metabolism defects.

Dr. Ranjana Singh

Dr. Ranjana Singh
Professor
Department of Biochemistry
Faculty of Medicine
King George’s Medical University
Lucknow, U.P., India
Mob. No. 9936862063
e-mail: ranjanasingh.2509@rediffmail.com, ranjanasingh@kgmcindia.edu

Achievements:
- Qualified Gate 95: 95 percentiles
- Research Experience: 29 years
- Teaching Experience: 27 years
- MD Thesis: 15 (Co-supervisor)
- PhD Thesis: 04 (Supervisor), 04 (Co-supervisor)
- Awards: 08
- Total Publications: 60
- Total Book Chapters: 07
- Research Projects: 02 (as PI), 02 (as co-PI), 04 (as Mentor)
- Citations: More than 1500
- H-index: 24
- Scientific Programs Organized: 15
- Membership of Professional / Academic Bodies: 10

- Ph.D. (Medical Biochemistry) awarded in 2001.
- Member of National Academy of Medical Sciences (India) in 2023.
- Member of International Society of Biosphere and Cosmos (BIOCOS).
- Fellow of International Society of Medical Food and Nutrition in 2023.
- Treasurer of the Indian Academy of Biomedical Sciences.
- Treasurer of World Congress on Chronomedicine.
- Fellow of the International College of Nutrition (FICN).
- Excellence in research award for high impact factor paper published in Research Showcase 2022-23 organized by Research Cell, KGMU, Lucknow.
- Member of the advisory committee for DDU Kaushal Kendra, Rajiv Gandhi South Campus, Banaras Hindu University, nominated by the chairman UGC.
- Nodal Officer of University Environment Cell.
- Member - Anti-Ragging squad.
- Provost of DK & Chatra Chatrawas Hostels, KGMU, Lucknow.

Dr. Sadanand Naik

BIOGRAPHICAL SKETCH
Name: Naik, Sadanand Subray
Education:
- M.Sc. in Biochemistry, University of Bombay, Maharashtra, 08/1972
- Ph.D. in Medical Biochemistry, University of Pune, 05/1986
Positions:
- 1973-1998: Senior Biochemist
- 1998-Present: Head of the Department, K.E.M. Hospital, Pune, Maharashtra
- 2012-Present: Senior Consultant Biochemist, Deenanath Mangeshkar Hospital & Research Centre, Pune
- 1987-2012: Guide for M.Sc., Ph.D., and M.D. (Medical Biochemistry) at MUHS University & Symbiosis University
Awards & Fellowships:
- 2014: G.S. Medical College, Mumbai - Oration Award at ACBI
- 1985: Birla Smarak Kosh Scholarship (Postdoctoral Research at SRDU, Oxford, UK)
- 2000: British Council Fellowship (Inborn Errors of Metabolism, Sheffield, UK)
- 2004: Wellcome Trust Fellowship (Southampton, Finland, Bergen, Norway & Oxford)
Memberships & Editorial Roles:
- Group Member of International Federation of Clinical Chemistry
- Editorial Member for International Journal of Nutrition
Publications:
- S. Naik et al., "Daily milk intake improves vitamin B12 status in young vegetarian Indians: an intervention trial," Nutrition Journal, 2013, 12:136-44
- S. Naik et al., "Increase in circulating holotranscobalamin after oral administration of cyanocobalamin or hydroxocobalamin in healthy adults with low and normal cobalamin status," European Journal of Nutrition, 57(8), 2018
- S.S. Naik et al., "Identification of vitamin B12 deficiency in vegetarian Indians," British Journal of Nutrition, February 2018
- P.I. "Identification of a suitable milk product that can prevent vitamin B12 deficiency," funded by DBT, Delhi, India & DCSR, Aarhus, Denmark (IMPROVIT) 2015-2018
- P.I. "Daily milk intake by pregnant mothers improves the vitamin B12 status of mothers and offspring compared to vitamin B12 pills," funded by Danish Dairy Research Foundation, Aarhus, Denmark, 2020-2023

Dr. Sadhna Sharma

Professor, Department of Biochemistry

All India Institute of Medical Sciences
Bilaspur, Himachal Pradesh

Former Professor and Head, Department of Biochemistry, PGIMER, Chandigarh

Awards and Honors

• Fellow of National Academy of Medical Sciences
• Fellow of Indian Academy of Biomedical Sciences
• Fellow of the Association of Clinical Biochemists of India

Membership of Professional Organizations

• Association of Clinical Biochemists of India
• Indian Academy of Biomedical Sciences
• Society of Biological Chemists of India
• Contributing Member, American Society of Microbiology
• Member, European Federation of Clinical Biochemistry and Lab Medicine (2024)

Research Areas of Interest

Actively involved in research related to:

• Molecular basis of Tuberculosis
• Nanomedicine and its applications in infectious diseases and lung cancer
• Osteoarthritis

Employing various approaches like Proteomics, Genomics, Cell signaling, etc.

Research Grants

Have received extramural research funding from:

• DST
• CSIR
• ICMR

Research Publications

More than 100 publications in national and international journals of repute and several book chapters.

Google Scholar ID: Google Scholar

Total citations: 5640

h-index: 38

i10-index: 64

Dr. Sudha Srivastava

Prof. Sudha Srivastava, is an interdisciplinary person with her basic training in chemistry from Panjab University, Chandigarh followed by Ph.D in Theoretical Physics from Jawaharlal Nehru University in 2002 and post doctoral research in molecular biology from All India Institute of Medical Sciences (AIIMS) (2002-2004). In 2004 she joined Indira Gandhi National Open University (IGNOU) as consultant for planning and development of Post Graduate Diploma Program in Bioinformatics. Her research interests include nanobiotechnolgy, biosensors, ligand-receptor interactions. She has published papers in high impact factor journals of international repute and edited a book and written book chapters Recently, her group has successfully completed Technology Transfer of Thyroid Biosensor to a Swedish company. She has three granted patents to her credit - one Indian patent (thermally stable enzyme nanoparticles) and two European patents(thyroid biosensor, sperm infertility biosensor). Her expertise is in controlled chemical synthesis of biocompatible nanoparticles of metallic, non-metallic materials as well as biomolecules. Currently, the research focus is on diagnostic device development, synthesis of nanomaterials, use of nanotechnology for the development of biosensors with improved stability, sensitivity and response time. In addition to this she is also working on nanoparticles based vaccine development and detergent formulation.

Dr. Kalpana Luthra

Dr. Kalpana Luthra is Professor & Head, Department of Biochemistry, and Chief, Centre for Medical Education & Technology (CMETi), All India Institute of Medical Sciences (AIIMS), New Delhi, India. She completed her PhD at AIIMS in 1994 and joined as faculty at AIIMS in 1998. She was awarded the Fogarty fellowship in 2002 and availed training in HIV-1 antibody related work at New York University. The major focus of her work has been towards understanding the immune responses elicited by HIV-1 infected adults and children; generation of human anti-HIV-1 recombinant monoclonal antibodies as potential therapeutic reagents against HIV-1 and to map the neutralization determinants on the HIV-1C to identify Indian clade C specific epitopes for immunogen design. She is actively involved in ongoing national and international collaborative research projects in this area of research, as a PI and as Senior mentor. Recently, her research group successfully generated an anti-HIV-1 broadly neutralizing antibody from an Indian paediatric elite neutralizer. This antibody is being further characterized to evaluate its potential as an anti-HIV-1 reagent. Further her team has shown that distinct circulating viruses in chronic HIV-1 infected children are associated with maintenance of elite neutralizing activity in chronically HIV-1 clade C infected monozygotic pediatric twins. Her work on circulating HIV-1 in perinatally infected infants defined viral factors associated with early bnAb responses, supportive of polyvalent vaccination approaches capable of inducing bnAbs against HIV-1. She is a Fellow of the Indian National Science Academy (INSA), National Academy of Medical Sciences (NAMS) & the National Academy of Sciences India (NASI).

Dr. Sanjay Gupta

Dr. Sanjay Gupta
Dr. Sanjay Gupta was awarded his Ph.D. from Banaras Hindu University, Varanasi, in 1995, focusing on aging, chromatin biology, and gene regulation. After completing his Ph.D., he spent time as a visiting research associate at the Institute of Life Sciences, Bhubaneswar, and subsequently held post-doctoral and DST-young scientist fellowships.

He joined the Cancer Research Institute at Tata Memorial Centre, Mumbai, in 1999. Dr. Gupta has made significant contributions to epigenetics, particularly in the study of histone isoforms and variants, their site-specific post-translational modifications in cancer pathogenesis, resistance, and cell-cycle-specific DNA repair mechanisms. His research aims to understand how epigenetic mechanisms regulate gene expression in cancer, utilizing these insights for biomarker development and the discovery of epi-drugs for cancer therapy.

Dr. Sanjay Gupta has published numerous peer-reviewed research papers in international journals. He actively participates in national and international committees such as SERB, HPU-Ministry of Electronic and IT, and UICC. He is the Associate Editor of the Journal of Integrated–Omics, an Editorial Board Member of the Journal of Clinical Epigenetics, and an Associate Editor of the Journal of Radiation and Cancer Research. He has also developed the HISTome2 database (https://www.actrec.gov.in/histome2/), which integrates information on histone proteins and epi-drugs.

Dr. Sanjeev Galande

Dr. Sanjeev Galande
Dr. Sanjeev Galande obtained his PhD in Biochemistry from the Indian Institute of Science in 1996. He pursued postdoctoral studies at the Lawrence Berkeley National Laboratory, USA from 1996 to 2001, where he focused on cancer biology.

In 2001, Dr. Galande joined the National Center for Cell Science in Pune, India, as a senior scientist. He furthered his career in 2010 as a Professor at the Indian Institute of Science Education and Research (IISER Pune). His research explores how dynamic changes in higher-order chromatin assembly regulate gene expression in a spatial and temporal manner.

In 2021, Dr. Galande became the Dean of the School of Natural Sciences at Shiv Nadar University (SNU), Delhi NCR. At SNU, he also leads the Center of Excellence in Epigenetics (CoEE), where he assembled a team to study the evolution of epigenetic mechanisms using multiple model systems. The CoEE focuses on epigenetic modifications and their roles in various biological phenomena, including gene expression, regeneration, cancer, behavior, aging, and evolution.

Dr. Galande has established a multidisciplinary program that integrates biochemistry, molecular biology, bioinformatics, cell biology, proteomics, and genomics. His lab's research aims to unravel the complex interactions between chromatin structure and gene regulation.

For more information, visit the lab's webpage: www.sglabepigenetics.com

Dr. Sanjeev Shukla

Dr. Sanjeev Shukla earned his Ph.D. in Biochemistry under the mentorship of Dr. Surekha M Zingde at the Advanced Centre for Treatment, Research, and Education (ACTREC), Navi Mumbai, in 2009. His academic journey took him to Georgetown University Medical Centre in Washington DC, where he explored TGF-beta signaling in hepatocellular carcinoma.

In 2010, Dr. Shukla joined Dr. Shalini Oberdoerffer's laboratory at the National Institutes of Health (NIH)/National Cancer Institute (NCI), Maryland. His notable discovery of a novel mechanism regulating alternative pre-mRNA splicing was published in Nature in 2011.

His work has earned him prestigious accolades, including the Wellcome Trust-DBT India Alliance Intermediate Fellowship and the SERB-STAR Award.

In May 2013, Dr. Shukla joined IISER Bhopal, where his research group focuses on epigenetic and alternative splicing aberrations in cancer. Their pioneering research has been published in high-impact journals such as EMBO, Cancer Letters, PNAS, Cell Death and Disease, NAR Cancer, Oncogenesis, iScience, Cell Reports, and JBC, reflecting their commitment to advancing the understanding of alternative splicing regulation.

Dr. Shukla’s research aims to unravel the complexities of alternative splicing and its impact on cancer, contributing significantly to the field of molecular biology and oncology.

Dr. Navneet Dhillon

Navneet Kaur Dhillon, Ph.D., is a distinguished tenured professor in the Pulmonary and Critical Care Division at the University of Kansas Medical Center. Her academic journey began with a B.S. and M.S. in Biochemistry from Panjab University, India, followed by a Ph.D. in Biochemistry from the Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Dr. Dhillon's research focuses on understanding the pathogenesis of infection-related cardiopulmonary diseases, especially pulmonary hypertension. Her laboratory explores the synergistic effects of HIV proteins and illicit drugs on pulmonary endothelial dysfunction, aiming to unravel the mechanisms driving these complications. Dr. Dhillon has published extensively, and her work on the involvement of extracellular vesicles in mediating vascular dysfunction in patients with COVID-19 and HIV-1 is widely recognized and quoted worldwide. She has been successful in securing multiple NIH and foundation grants and at one time had three NIH R01 awards to pursue these studies.

Dr. Dhillon holds numerous leadership roles, including Director of Pulmonary Research and Director of the Parker B. Francis Summer Fellowship Program. She is also the current president of the Infection and Pulmonary Vascular Disease Consortium (iPVDc). Over her career, she has received several prestigious awards, including the Outstanding Research Investigator Award and Noffsinger Investigator Award at her Institute, Parker B. Francis Speaker Award at the American Thoracic Society International meeting, the Junior Scientist Award from the Association of Scientists of Indian Origin in America, and the Young Investigator Award at the Conference on Retroviruses and Opportunistic Infections. In addition, she serves on several national and international study sections and is a reviewer for high-impact journals.

Dr. Dhillon continues to mentor early-career investigators and leads initiatives that promote multidisciplinary collaborations aimed at addressing infection-associated cardio-pulmonary diseases.

Dr. Savita Yadav

Dr. Savita Yadav is a Professor of Biophysics at All India Institute of Medical Sciences (AIIMS), New Delhi, with over 25 years of experience as an academician and researcher. Her research primarily focuses on reproductive science and 'Omics' technology.

As a prominent researcher, Dr. Yadav has been instrumental in developing and implementing innovative methodologies in her field. She has published more than 100 high-quality research papers in reputed international journals and has secured funding for projects from national bodies including ICAR, ICMR, DST, DBT, MoE&F, and BIRAC.

Dr. Yadav has also been a key organizer of conferences, seminars, and workshops in the areas of biomedical sciences and reproductive health. Her contributions have been recognized with several prestigious awards, such as the Fellowship of the National Academy of Medical Sciences, SERB-POWER Fellowship, AIIMS Excellence Award in Oncology, Hari-Om-Trust Memorial Award of ICAR, Dr. S. S. Guraya Memorial Oration Award, Technology Showcase IKMC Award, G.P. Talwar Award, and AIIMS Research Excellence Award.

Internationally, Dr. Yadav has presented her work in countries including Japan, Germany, Italy, USA, UK, Czech Republic, and Portugal.

Beyond her scientific achievements, Dr. Yadav is deeply engaged in social work, particularly in reproductive health awareness programs conducted in various urban and rural schools.

Dr. Seema Bhargava

MBBS, DNB, PhD, MNAMS, FACBI, FRCPath
Chairperson & Senior Consultant, Department of Biochemistry & Professor, GRIPMER (Ganga Ram Institute of Postgraduate Medical Education and Research), Sir Ganga Ram Hospital, New Delhi, India.

Roles and Memberships:
- Immediate Past President, ACBI (Association of Clinical Biochemists of India)
- Member, IFCC EBLM-C (International Federation of Clinical Chemistry-Evidence Based Laboratory Medicine Committee)
- Member, IFCC Task Force for LMPG (Laboratory Medicine Practice Guidelines)
- Immediate past-Chairperson, CAHO-DD (Diagnostic Division, Consortium of Accredited Healthcare Organizations)
- Director, Delhi Chapter of Foundation Quality (India)

Major Achievements:
- Dr. T.N. Pattabhiraman Oration, 2023
- Long Service Awards – awarded by SGRH in April 2023 for 30 years’ service, and previous 20 years’ and 25 years’ awards
- IMA NDB Award of Excellence, November 2021
- Fellow of Royal College of Pathologists [FRCPath], 2019
- Fellow of ACBI [FACBI], 2018
- Dharam Vira Award of Excellence by SGRH in January 2014
- James Willerson Clinical Award, International Academy of Cardiovascular Sciences, August 2013
- Gold Medal for ‘Best Publication, 2012’ by GRIPMER, April 2013
- ‘Best Zonal Representative’ award of ACBI, 2016
- Assessed over 100 labs as Lead and Technical Assessor for NABL
- Member of Accreditation Committee of National Accreditation Board For Testing And Calibrating Laboratories (NABL)

Publications:
- 1 book (sole author)
- 55 papers
- 17 chapters
- 93 abstracts

Research Interests:
Dr. Bhargava's research focuses on identifying new clinically relevant biomarkers, particularly for vascular disease, stroke, diabetes, and Alzheimer’s disease.

Dr. Jay Kalra

Dr. Jawahar (Jay) Kalra is a professor and clinical pathologist in the Department of Pathology and Laboratory Medicine. He has served as Department Head of Pathology and Laboratory Medicine in the Saskatoon Health region. Dr. Kalra received his Doctor of Medicine (MD) degree from Memorial University of Newfoundland and completed his residency training at the University of Ottawa. He is a Fellow of the Royal College of Physicians and Surgeons of Canada, the Canadian Academy of Health Sciences, a Life Fellow of the Royal Society of Medicine, UK, and a Canadian Certified Physician Executive Leader (CCPE).

Dr. Kalra has served as a member of the Board of Governors at the University of Saskatchewan and currently serves as Vice-Chair on the Board of Directors of the Council of Canadian Academies (CCA). He has also been the national president of various medical associations and scientific societies, including the Canadian Association of Medical Biochemists and the Canadian Association of Pathologists. A founding member (1991) and Director (1998-2000) of the Saskatchewan Stroke Research Centre, he has contributed to several department, college of medicine, and health region committees. He currently serves on the board of directors of the Saskatchewan Medical Association (SMA) and its Legislation and Policy Committee.

Dr. Kalra has actively participated as a physician leader in healthcare reform and administrative roles. He has served as Clinical Chief (Head) of the Department of Lab Medicine Saskatoon District Health, a member of the executive medical advisory committee, founding chair of the Saskatoon District Health Infection Control Committee, and a member of the clinical review panel for the distribution of clinical services in the Saskatoon Health Region.

He is the author of the book “Medical Errors and Patient Safety – Strategies to Reduce and Disclose Medical Errors and Improve Patient Safety,” and has championed the establishment of a non-punitive “no-fault model” to address clinical/medical errors, along with developing educational programs and clinical guidelines reflecting evidence-based medicine. Recently, he has been working in the area of Artificial Intelligence (AI) and its implications (ethical, legal, and regulatory issues) in Medicine and Healthcare.

Dr. Kalra is a recipient of more than 30 awards and honors, including: Rotary Golden Wheel Award for Excellence in Science and Technology; Saskatchewan Health Research Foundation Achievement Award in Clinical Research; Queen Elizabeth II Platinum Jubilee Medal; RBC 2013 Top 25 Canadian Immigrant Award; and CTV 2015 Saskatoon Citizen of the Year Award, among many others.

Dr. Shailendra Giri

The major goal of Dr. Giri's research program is to understand the role of metabolic derangement in multiple sclerosis (MS) and other neurological diseases. His research focuses on the following areas:

1. Pathogenesis of MS: Understanding the factors responsible for the development of MS through preclinical mouse models and various gene/cell-specific knockout mice.

2. Metabolic Profiling: Identifying blood-based metabolites and altered metabolic pathways in MS patients using advanced technologies to monitor MS progression and response to therapy.

3. Functional Outcomes: Exploring the relationship between metabolic alterations and functional outcomes, including immune response and myelination/remyelination.

4. Disease Resolution: Investigating why the disease-resolving system is disrupted during chronic inflammation.

Dr. Giri’s approach of integrating bench-to-bedside research aims to provide a deeper understanding of the etiopathogenesis of MS and develop novel therapeutic modalities to cure the disease.

Dr. Sucheta P. Dandekar

Dr. Sucheta Dandekar, formerly Professor & Head of the Department of Biochemistry at Seth G.S. Medical College & K.E.M. Hospital, Mumbai, is currently a Professor of Biochemistry at Era's Lucknow Medical College, Lucknow. She also serves as adjunct faculty at the Manipal Academy of Health Education.

A prolific writer, Dr. Dandekar has authored several books and published numerous articles in both national and international journals. She is a founder member of the GSMC-FAIMER regional institute and has been involved with PSG-FAIMER and MAHE-FIILIPE regional institutes.

She has been honored with various awards including the Seth G.S. Medical College & K.E.M. Hospital Oration, the Awadhesh Saran Oration, and the University of Mumbai Oration in Biochemistry. Dr. Dandekar received the Best Teacher Award from the Maharashtra University of Health Sciences. In July 2024, she was awarded the MEU India’s Dr. Rita Sood Memorial Oration and the Lifetime Achievement Award.

Dr. Dandekar is a FAIMER Philadelphia 2010 fellow and holds an International Fellowship in Medical Education (IFME). She completed her Master’s in Health Profession Education (MHPE) from Keele University, U.K. Currently, she is a global faculty member and project advisor at the International FAIMER Institute, Philadelphia. She also serves as a member of the Quality Assurance Committee and a Global Consultant at FAIMER.

Dr. Dandekar has also served as an assessor for NABL and has presented her research work at numerous national and international conferences.

Dr. Sudip Sen

Dr. Sudip Sen is a Professor in the Department of Biochemistry at the All India Institute of Medical Sciences (AIIMS), New Delhi. He completed his MD and PhD from AIIMS, Delhi, and joined the faculty there in 2012. His initial research focused on cancer diagnosis and therapeutics. Over time, his interests shifted towards stem cells and disease modeling, particularly after working on ocular surface reconstruction as a DST Fast Track Fellow.

For the past few years, Dr. Sen's research group has been engaged in studying mesenchymal stem cells, cancer stem cells, and neural stem cells. They have made significant contributions to understanding fetal brain development in utero and have published notable papers on oligodendrocyte development and the effects of hypoxia on fetal brain development.

His work has garnered recognition at both national and international levels, with research grants, publications, and awards acknowledging his contributions to the field.

Dr. Sunil K Arora

Dr. Sunil K. Arora did his M.Sc. (Hons School) in Biochemistry from PU, Chandigarh in 1980 and then got his Doctoral degree (PhD) in Immunology from the Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India in 1987. He received his post-doctoral training in Molecular Immunology from the famous Department of Medicine, Division of Infectious Diseases in University of Texas Health Science Center at San Antonio, Texas USA. Subsequently he was faculty in the Department of Immunopathology at PGIMER, Chandigarh where he was elevated to full Professor in 2008 and retired on 30th Sept., 2023. He remained as Head, Department of Translational & Regenerative Medicine at PGIMER Chandigarh, from 2013 till his retirement. He is elected member of the National Academy of Medical Sciences (India) since 2004. He is past-President of Indian Immunology Society and The Cytometry Society (India) and is current President of The Federation of Immunological Societies of Asia-Oceania (FIMSA) till 2024. He was Professor-in-charge of the NACO center for HIV Diagnosis and Disease Monitoring at PGI till his retirement. His research work focused on the Immunological aspects of Infectious Diseases mainly HIV, HIV-TB co-infection, HCV and Experimental Leishmaniasis. His team has worked on identification and evaluation of protective efficacy of novel vaccine candidates for kala azar. Besides, his lab has been working to delineate the cellular immune defects in HIV and HCV infections. Additionally, he is working in the field of stem cells with special interest in role of cancer stem cells in breast carcinoma and immunomodulatory-cum-regenerative capacity of mesenchymal stem cells in chronic autoimmune inflammatory arthritis. He has guided 25 PhDs to completion with 179 scientific publications to his credit in the peer-reviewed journals of repute. He has received many awards including Indo-US Young Investigator’s award in 1991, Indo-US Fogarty Fellowship in 2012, Senior Scientist Oration award in Immunology in 2018 and Distinguished Alumnus Award of Panjab University, Chandigarh 2023.

Dr. Sukhes Mukherjee

Dr. Sukhes Mukherjee is an Additional Professor in the Department of Biochemistry at AIIMS Bhopal. With over 17 years of experience in teaching and research, he has built a robust academic and research career. Dr. Mukherjee has published more than 104 papers in peer-reviewed journals and has presented his work at numerous national and international conferences.

He was honored with the Best Paper Award by the Association of Clinical Biochemists of India in 2008. He also received an International Travel Fellowship to attend the Neurochemistry conference in Busan, South Korea in August 2009 and an AACC Fellowship in 2011.

Dr. Mukherjee regularly provides training for undergraduate and postgraduate medical students and is actively engaged in learning cutting-edge technologies in Advanced Biology, Biochemistry, and Molecular Biology. Recently, he was elected as a Fellow of the Royal Society of Medicine, UK, and inducted as a Member of the National Academy of Medical Sciences, India (MAMS) in 2020. He was also inducted into the Royal Society of Public Health, UK in 2022 and is a member of the Royal Society of Biology (UK).

His research interests include Clinical Biochemistry, Precision Oncology, and Biochemical Insights into Metabolic Diseases.

Dr. Tapasya Srivastava

Dr. Tapasya Srivastava is currently serving as the Head of the Department of Genetics at the University of Delhi South Campus, a position she has held since 2009. She has made significant contributions to research in medical genetics, cancer genetics, epigenetics, and the biology of the tumour microenvironment. Her research efforts are supported by grants from various funding agencies, including the University of Delhi.

Dr. Srivastava has published numerous international peer-reviewed papers and book chapters, reflecting her active engagement in advancing these fields. Her laboratory is also involved in training PhD students and undergraduate and postgraduate students, particularly from smaller universities and colleges.

In addition to her research and teaching responsibilities, she is actively involved in several committees, including funding agency committees, institutional ethics committees, and governing bodies in various colleges. She also serves on boards of research studies in multiple institutions.

Dr. Tavpritesh Sethi

Dr. Tavpritesh Sethi is an Associate Professor in the Department of Computational Biology and the founding head of the Center of Excellence in Healthcare at IIIT-Delhi. His research sits at the intersection of computer science and healthcare, focusing on the application of AI and ML to enhance medical outcomes.

His research interests include:
(i) Early prediction of critical outcomes in Intensive Care Units (ICUs) for conditions such as sepsis, shock, and antimicrobial resistance.
(ii) Pandemic surveillance and management.
(iii) Multi-modal algorithms for signal enrichment from heterogeneous healthcare datasets.

Dr. Sethi's lab has developed and deployed a data lake and an early warning system for predicting sepsis in pediatric and neonatal ICUs. Additionally, he has been instrumental in developing various COVID-19 management and surveillance strategies utilizing data and AI.

He earned his M.B.B.S from Government Medical College, Amritsar, and a Ph.D. from CSIR-Institute of Genomics and Integrative Biology, New Delhi. Prior to his tenure at IIIT-Delhi, he worked as a research officer at the All India Institute of Medical Sciences, New Delhi, and as a CSIR Quick Hire Fellow at CSIR-Fourth Paradigm Institute. He also served as a visiting faculty member at Stanford University in the Department of Biomedical Informatics Research.

Dr. Sethi is a Sigma Xi Fellow, a DBT/Wellcome India Alliance Fellow, and a Kavli Fellow. He has published over 50 papers in international journals and serves as an academic editor for PLOS One, Nature Scientific Reports, PeerJ, and the Journal of Genetics. He is also a TEDx speaker and has delivered keynote addresses at numerous national and international conferences on data and AI in healthcare.

Dr. Sethi is involved with the Scientific Advisory Committees of the ICMR National Institute of Epidemiology and ICMR National Institute of Occupational Health.

Dr. Shailja Sharma (MBBS MD MRSB MNAMS)

Dr. Shailja Sharma is Additional Professor of Biochemistry at All India Institute of Medical Sciences Jodhpur. She has over twelve years of experience in research and teaching in different medical institutes in India and abroad. She has presented papers and posters as well as chaired sessions in National and International Level Conferences. She has more than 40 publications in national as well as international journals and is a reviewer for many National and International Journals. Her areas of research and academic interest are in the fields of Biochemistry, molecular medicine, heavy metal toxicity, and medical education.

She has taught courses in the mentioned fields to postgraduate and undergraduate students. Dr. Sharma has been associated with All India Institute of Medical Sciences for over 10 years, contributing to developing programs, curricula, research, and teaching resources in the department. She enjoys designing workshops, practicals, and scientific activities that enhance the conceptual understanding of the subject matter.

As coordinator of the Western Region Lead Referral Centre NRCLPI, she is actively involved in disseminating awareness in the community and schools regarding lead toxicity and conducts regular awareness programs in schools regionally to disseminate knowledge on ways to overcome this problem. She is working on several projects related to Pb toxicity, focusing on exploring the molecular basis of lead toxicity and the role of this metal in health and disease.

Dr. Stefan Holdenrieder

Stefan Holdenrieder is Deputy Director of the German Heart Centre Munich (GHC), Hospital of the Technical University Munich (TUM), Director of the Institute of Laboratory Medicine at the GHC, and Head of the Munich Biomarker Research Center (MBRC).

He is President of the International Society of Oncology and BioMarkers (ISOBM), a member of the WHO-IARC Collaboration for Cancer Classification and Research (IC3R) Steering Committee, and Principal Investigator in the European consortia WCT EVI-MAP and GenomeMet. On the national level, he is a member of the Guideline Commission of the German Society of Clinical Chemistry and Laboratory Medicine (DGKL), Vice Speaker of the DGKL Competence Field “Molecular Diagnostics,” Delegate at the Steering Group D5 “Molecular-genetic and cytogenetic investigations” of the German Medical Association, and External Quality Assessment Consultant for Tumor Marker ring trials at Instand e.V.

Prof. Holdenrieder has organized several scientific conferences (ISOBM, CNAPS, MEDICA LabMed Forum), is Associate Editor of the Journal of Laboratory Medicine, MDPI Diagnostics, Journal of Clinical Medicine, Tumor Biology, and Frontiers of Cardiovascular Medicine, and has published more than 270 scientific papers in international peer-reviewed journals.

Dr. Amitava Das Gupta

Amitava Dasgupta received his Ph.D. in chemistry from Stanford University and completed his fellowship in Clinical Chemistry from the Department of Laboratory Medicine at the University of Washington School of Medicine in Seattle. He is board certified in both Toxicology and Clinical Chemistry by the American Board of Clinical Chemistry and has been a member of ADLM since 1987. He is also a fellow of the academy.

Currently, he is a tenured Full Professor of Pathology and Laboratory Medicine at the University of Kansas Medical Center and Director of Clinical Laboratories at the University of Kansas Hospital, as well as vice chair for clinical pathology. In his early career, he focused on the clinical utility of free (unbound) drug monitoring and received the Young Investigator Award from the AACC (now ADLM).

Later, he continued his research in therapeutic drug monitoring and toxicology. In 2009, he received the Irvine Sunshine Award from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for his research on identifying adulterated urine specimens submitted for workplace drug testing. He also received the Outstanding Contribution in Education Award from AACC in 2010. In 2024, he received the Academy of ADLM Award for outstanding contribution in clinical chemistry in a selected area of research.

Dr. Das Gupta has published 264 scientific papers, 20 invited review articles, several editorials, and over 100 abstracts. He has written 15 books and edited or co-edited another 11 books. He is on the Editorial Board of five journals, including Archives of Pathology and Laboratory Medicine, Therapeutic Drug Monitoring, Clinica Chimica Acta, Journal of Clinical Laboratory Analysis, and Annals of Clinical and Laboratory Science.

Dr. Endang Hoyaranda

PERSONAL DATA
Name: Endang Wahjuningtyas Hoyaranda-Soedarmo
Place/date of birth: Yogyakarta, October 21, 1951
Citizenship: Indonesia
Gender: Female

EDUCATION
1976: Bachelor in Pharmacy, Institute of Technology Bandung – Indonesia
1977: Pharmacist, Institute of Technology Bandung – Indonesia

WORKING EXPERIENCES
1976 – 1982: Lecturer, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Bandung Institute of Technology, Indonesia
1979 – 1982: Secretary to the Pharmacy Department, Faculty of Mathematics and Natural Sciences, Institute of Technology, Bandung – Indonesia
1982 – 1990: Research and Development (R&D) Manager, Prodia Clinical Laboratory
1990 – 2002: Operation Director at Prodia Clinical Laboratory
2003 – 2009: President Director at Prodia Clinical Laboratory
2009-present: Commissioner, Prodia Clinical Laboratories
2008 – present: Commissioner, Prodia the CRO
2009 – present: President Director Prodia Utama, Holding Company of Prodia Group
2009 – present: Commissioner, Prodia Occupational Health Institute
2010 – present: Commissioner, Prodia Stem Cell Indonesia
2010 – present: Commissioner, Prodia Innovasi Diagnostika
2011 – present: Commissioner, Prodia Diagnostic Line
2015 – present: Chairperson, Grhanis Group
2014 – 2016: Leading Team for Prodia Widyahusada Initial Public Offering
2021 – present: Commissioner, Prodia Distribusi Medika
2023 – present: Commissioner, Prodia Digital Indonesia

• Additional assignments:
o Lecturer in Laboratory Management, University of Hasanuddin (Makassar) – 2003-2006
o Lecturer in Entrepreneurship, University of Hasanuddin (Makassar) – 2003-2006
o Lecturer in Medical Laboratory Ethics, Jakarta Health Polytechnics – 1997 - present

PROFESSIONAL ACTIVITIES:
INDONESIAN ASSOCIATION FOR CLINICAL CHEMISTRY
2000 – present: Executive Board, various functions

INDONESIAN ASSOCIATION OF MEDICAL LABORATORY TECHNOLOGISTS (PATELKI)
1997-2000: Secretary General
2000-2006: President
2006 – present: Advisor

ASEAN ASSOCIATION OF CLINICAL LABORATORY SCIENCES (AACLS)
1995 – 1997; 2006-2008: President

ASIAN ASSOCIATION OF MEDICAL LABORATORY SCIENCES (AAMLS)
2001 – 2023: Executive Board, various functions

ASIA – PACIFIC FEDERATION FOR CLINICAL BIOCHEMISTRY AND LABORATORY MEDICINE
2001 – 2004: Member, Education Committee of the Asia-Pacific Federation for Clinical Biochemistry (APFCB)
2004 – 2010: Chairperson, Education Committee
2010 – 2016: Secretary
2016-2021: Vice President
2022: President

INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE
2011 – 2017: Member, Committee for Distance Learning
2011-2020: Member, Committee for Public Relations
2022 – 2023: Executive Board, APFCB Representative

INDONESIA ASSOCIATION FOR THE STUDY OF MEDICINALS
2009 – 2017: Treasurer
2017-present: President

INDONESIAN INSTITUTE FOR CORPORATE DIRECTORSHIP
2012 – present: Vice President

INDONESIAN COALITION FOR ANTI-CORRUPTION (KOALISI ANTI KORUPSI INDONESIA)
2020 – present: Advisory Committee

INDONESIAN INSTITUTE FOR COMPETENCY CERTIFICATION OF LABORATORY TECHNOLOGISTS (LSP-TELAPI)
2003 – 2022: Vice Chair

SOCIAL AFFILIATIONS:
1. Rawinala Foundation, School for Double Disabled Children, Jakarta, Chairperson, 2020 – present: Chair of the Board of the Foundation

LANGUAGE SPOKEN:
Bahasa Indonesia
English
Dutch

Awards:
1. BNSP Competency Awards, 2008
2. BioPharma Industry Award – Woman Executive of the Year, 2013
3. Indonesian Association for Clinical Chemistry Award, 2019
4. Inspirational Leader Award, Bandung Institute of Technology, 2022

Jakarta, 24 September 2024

Dr. Veena Puri

Dr. Dr. Veena Puri

Professor, Chairperson
Centre for Systems Biology and Bioinformatics
Panjab University, Chandigarh
Email ID: vpuri1825@pu.ac.in

Area of Research: Transcriptomic data analysis and signal transduction.

Dr. Puri began her research career with a Master's and Doctoral degree from PGIMER, Chandigarh, focusing on state-of-the-art technologies in protein chemistry. Her initial overseas research assignment in the USA at Dr. Chandran's lab enhanced her expertise in understanding the mechanisms of herpes virus infection. She continued her work with Professor Nancy Berman at the University of Kansas Medical Center, where she studied the role of ovarian steroids in menstrual migraine.

During this period, Dr. Puri produced several influential research papers and presented numerous abstracts at international conferences, gaining significant scientific attention. Notably, a paper presented at the Society for Neuroscience meeting in New Orleans in November 2003 was included in the press release. Her pioneering work on Ghrelin in neurons was recognized among the Top 25 articles in Neurosciences by Science Direct. Her 2006 publication received the prestigious Harold G. Wolff Lecture Award in Headache Research.

After returning to India, she established her research group with major grant funding from UGC (2011-2014) for a project on ovarian steroids and menstrual migraine. In 2019, she received DST UT funding to explore the Reno-Neural axis in acute kidney injury. In 2021, she participated in a DBT multi-department funding project, establishing a Core Bioinformatics group at the University. Her department has been recognized as a major Bioinformatics Centre at the national level, supported by another DBT National Network Project in collaboration with NIPER, Mohali.

Dr. Dharmveer Yadav

Presently working as Additional Professor of Biochemistry at AIIMS, Jodhpur. He has published over 70 research papers in various international and national journals.

Roles:
- Faculty In-charge of Paramedical Courses at AIIMS Jodhpur
- Member of Institutional Animal Research Ethics Committee

Scientific Leadership Contribution:
- Vice President of Association of Clinical Biochemists of India for the year 2015-16
- Associate Editor of Indian Journal of Clinical Biochemistry
- Secretary of Rajasthan Chapter of Association of Clinical Biochemists of India
- Executive Member of North Zone ACBI from 2016 to present
- State Representative of Rajasthan for ACBI (2012 - 2015)
- Member, Executive Council, Association of Clinical Biochemists of India (2010-2012)

Academic Honors and Awards:
- Best Zonal Council Member of ACBI (2023)
- Travel Grant to attend APSAL (Asia Pacific Association for the Study of the Liver) (2022)
- Best Oral Paper Award in National Conference on Environmental Toxicity (2021)
- Best Poster Paper Award in National Conference on Environmental Toxicity (2021)
- Best Poster Award in APFCB Congress (2019)
- AFMC Quiz Award (ACBICON 2012)
- ACBI Travel Grant Award (2008)
- ACBI Travel Grant Award (2005)

Dr. Christa M. Cobbaert

Christa M. Cobbaert, PhD, EurSpLM, is a Professor of Clinical Chemistry and Laboratory Medicine in the Department of Clinical Chemistry and Laboratory Medicine at Leiden University Medical Centre (LUMC), Leiden, the Netherlands. She has been heading the department since 2009.

Dr. Cobbaert is a European Specialist in Laboratory Medicine. Her research focuses on Precision Diagnostics, utilizing quantitative bottom-up proteomics to refine the molecular definition of Health and Disease. She currently chairs the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Scientific Division Executive Committee, which is involved with metrological traceability of test results and standardization of medical tests (IFCC Scientific Division). She is also a member of ISO TC 212 working group 2 on Reference Systems and a personal member of the EURAMET Research Council.

In Europe, she represents the European Federation in Laboratory Medicine (EFLM) in the IVD subgroup of the Medical Device Coordination Group during meetings with the European Commission on the implementation of the IVDR 2017/746. In this capacity, she chairs the EFLM Task Force on European Regulatory Affairs (EFLM Task Force).

Her work has resulted in approximately 230 original publications, multiple lectures/webinars, and several appointments to (inter)national positions due to her expertise in precision diagnostics using quantitative bottom-up proteomics and in metrology and reference standardization of medical tests.

Dr. Nilesh Chandra

Dr. Nilesh Chandra, MBBS, MD (Biochemistry), is currently serving as a Scientist E and Program Officer in the Discovery Research Division at the Indian Council of Medical Research (ICMR), under the Ministry of Health and Family Welfare.

He has previously held the position of Head of Clinical Chemistry & Immunology at Healthians Reference Laboratory in Gurgaon and was an Assistant Professor in the Department of Biochemistry at Subharti Medical College, Meerut.

Dr. Chandra is the author of "Biochemistry - High Yield," a popular book for MBBS students, and has contributed several chapters in various Biochemistry textbooks. He has published numerous original research articles in both national and international journals.

Additionally, he is a recognized faculty member for paramedical courses at NIOS and IMA.

Dr. Sudip Kumar Datta

Dr. Sudip Kumar Datta completed his MD in Biochemistry from UCMS, Delhi, in 2010 and is currently serving as Additional Professor & Head, Department of Laboratory Medicine at AIIMS, New Delhi.

He established the first integrated, end-to-end Total Laboratory Automation in the SMART Lab at AIIMS. Dr. Datta is a member of several international and national bodies, including the International Federation of Clinical Chemistry (IFCC) Task Force on Ethics, ICMR Task Force for Establishment of Reference Intervals in the Indian Population (TERIP), and serves as Chairman of the Medical Laboratory Instruments Sectional Committee, MHD-10 at the Bureau of Indian Standards (BIS).

He is a Technical Assessor for Clinical Biochemistry at NABL as per ISO 15189:2012 and 2022, and an executive member of several professional bodies such as ACBI, ADLM-India Chapter, AMBI, and ACCLMP. Dr. Datta has published over 50 original articles and more than 80 abstracts in journals of international and national repute, and has delivered lectures at various national and international forums.

He serves on the editorial board of the Journal of Laboratory Physicians and has received multiple awards, including International Travel Grants from AACC and IFCC. His research interests include the role of genetic and environmental factors in Chronic Kidney Disease, Total Laboratory Automation, development of mobile-based POCT devices, and ethics in laboratory medicine.

Dr. Sudip Kumar Datta

Dr. Sudip Kumar Datta completed his MD in Biochemistry from UCMS, Delhi, in 2010 and is currently serving as Additional Professor & Head, Department of Laboratory Medicine at AIIMS, New Delhi.

He established the first integrated, end-to-end Total Laboratory Automation in the SMART Lab at AIIMS. Dr. Datta is a member of several international and national bodies, including the International Federation of Clinical Chemistry (IFCC) Task Force on Ethics, ICMR Task Force for Establishment of Reference Intervals in the Indian Population (TERIP), and serves as Chairman of the Medical Laboratory Instruments Sectional Committee, MHD-10 at the Bureau of Indian Standards (BIS).

He is a Technical Assessor for Clinical Biochemistry at NABL as per ISO 15189:2012 and 2022, and an executive member of several professional bodies such as ACBI, ADLM-India Chapter, AMBI, and ACCLMP. Dr. Datta has published over 50 original articles and more than 80 abstracts in journals of international and national repute, and has delivered lectures at various national and international forums.

He serves on the editorial board of the Journal of Laboratory Physicians and has received multiple awards, including International Travel Grants from AACC and IFCC. His research interests include the role of genetic and environmental factors in Chronic Kidney Disease, Total Laboratory Automation, development of mobile-based POCT devices, and ethics in laboratory medicine.

Dr. Suchitra Kumari, MBBS, MD

Designation: Additional Professor
Room No. 136, Department of Biochemistry
All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India - 751019

Fellowships:
- Fellow of IMA Academy of Medical Specialities (2016)
- Fellow of International Medical Sciences Academy (2017)
- Member of National Academy of Medical Sciences (India) (2018)
- Elected Editorial Board Member of Asia Pacific Journal of Cancer Biology

Teaching Experience:
Dr. Suchitra Kumari has been a faculty member at state medical colleges and prestigious national institutes for over 17 years. She is currently an Additional Professor at AIIMS Bhubaneswar. She has mentored numerous MD Biochemistry postgraduates, PhD students, and MBBS students for ICMR short-term studentships.

Research Experience:
Dr. Kumari has conducted extensive research in the field of extracellular matrix in ovarian cancer patients, integrating her findings with artificial intelligence and machine learning models to improve patient care. She has received research grants from DST, India, and has completed five funded research projects. She has more than 50 publications in high-impact national and international journals.

Selected Publications:
1. P P A, Kumari S, Rajasimman AS, Nayak S, Priyadarsini P. Machine learning predictive models of LDL-C in the population of eastern India and its comparison with directly measured and calculated LDL-C. Annals of Clinical Biochemistry. 2022;59(1):76-86. doi:10.1177/00045632211046805

2. Kumari, S., Nayak, S., & Mangaraj, M. A New Machine Learning Approach for Actual Calcium Measurement. Indian J Clin Biochem, 2024. https://doi.org/10.1007/s12291-024-01182-3

Dr. Molly Jacob

Dr. Molly Jacob is a Professor of Biochemistry at Christian Medical College (CMC), Vellore in Tamil Nadu, India. She completed her undergraduate medical training (1986) and subsequent specialization in Biochemistry (1992) at the same institution. She was subsequently awarded a PhD degree from King’s College London in the UK in 1999. She was conferred the Fellowship of the Royal College of Pathologists in the UK (2019), based on her published work. Her current areas of research interest lie in the study of iron metabolism in various medical conditions. These include anemia (iron-deficiency anemia and anemia of inflammation) (with specific focus on women and in pregnancy), gestational diabetes mellitus, type 2 diabetes mellitus and alcoholic liver disease. She also has a keen interest in innovations in undergraduate medical education and postgraduate training and has set up effective programs for these in her department over the last 20 years.

She has numerous research collaborations with institutions in India and overseas. She has received considerable extramural funding for her research work, from both national and international agencies. Her work has resulted in numerous peer-reviewed research publications in journals of high quality. She has also been a co-author of the last 4 editions of the textbook Harper’s Illustrated Biochemistry.

Dr. Deepak Parchwani

Dr. Deepak Parchwani is a distinguished Professor in the Department of Biochemistry at All India Institute of Medical Sciences Rajkot (AIIMS Rajkot), India. He is also holding the post of state representative of Gujarat for Association of Clinical Biochemistry of India.

He is also a Coordinator, Asia Pacific Federation of Clinical Biochemistry and Laboratory Medicine Webcast & e-Learning Programme, along with serving as an Associate Editor of APFCB e-News & Publications. In addition, he is a Member of Communication and Publication Committee of APFCB.

With extensive experience of more than 23 years and expertise in the field of biochemistry and molecular biology, Dr. Deepak Parchwani actively engages in research endeavors. He has contributed to numerous scientific publications, which assisted in the advancement of understanding of various biochemical processes and their clinical implications. His research work focuses on areas viz molecular biology, enzymology, and metabolic disorders.

He actively participates in conferences, seminars, and workshops, where he shares his expertise and learns from other researchers in the field. He has numerous research papers & abstracts to his credit in reputed National & International journals. He is associated with various reputed journals as an editorial board member, reviewer and advisory board member.

Dr. Taruna Madan Gupta

Taruna Madan, M.Pharm. PhD , Scientist G and Head, Division of Development Research, Indian Council of Medical Research, Delhi.

With a PhD in Pharmacy from CSIR-IGIB and College of Pharmacy, University of Delhi (now DIPSAR, DPSR University), Dr. Madan did her post-doctoral training with Professor KBM Reid and Prof. Uday Kishore, MRC Immunochemistry Unit, University of Oxford, UK; and Dr. Raina Fichorova, Brigham and Women’s Hospital, Harvard Medical School, USA.

She is President of Indian Immunology Society, a recipient of 2022- ISSRF-Mridula Kamboj Oration, 2018-IUSSTF-WISTEMM-Senior Scientist Fellowship Award; 2016-ACBI-Mrs. and Dr. G. P. Talwar Oration Award; 2003-CSIR Young Scientist and 1998-INSA Young Scientist Medal.

Her group has over 100 peer-reviewed publications with more than 5000 citations (h index 35), 8 granted patents, 1 multi-institution validated product and an ICMR policy brief at the intersection of immuno-regulatory, pattern recognition proteins (PRRs) and human health with a focus on host-defense, cancer and reproductive disorders.

Dr. Sanjana Dayal

Dr. Dayal earned her PhD from All India Institute of Medical Sciences, New Delhi, India. Thereafter, she joined the laboratory of Dr. Steven Lentz in the Department of Internal Medicine, University of Iowa, for postdoctoral training. She pursued her research interests in delineating mechanisms of thrombosis associated with cardiovascular risk factors and developed an independent research program in aging and prediabetes associated platelet activation and thrombosis. Eventually she expanded her research program to study other risk factors associated with thrombosis, such as COVID-19 and cancer. Dayal lab investigates mechanisms of thrombosis using sophisticated animal models and clinically relevant human samples. She has established methods to conduct in vivo models of experimental thrombosis (for arterial as well as venous systems) in mice. We have also developed assays to monitor ex vivo platelet activation, aggregation, and thrombus formation in human samples. A new research direction is to study the involvement of extracellular vesicles, autoantibodies, NETs (neutrophil extracellular traps) and mitochondria in thrombosis. A secondary interest is to investigate mechanisms of cognitive impairment in aging. The Dayal laboratory is currently funded through a R01 from National Institute of Allergy and Infectious Diseases (NIAID, NIH), Heart Lung and Blood Institute (NHLBI, NIH) and VA Merit Award (CSRD), as well as through internal research funds. She lives in Marion, IA with her family. Her husband Abhas Kumar a product of IIT, BHU, is now a retired computer engineer. She has a daughter Deeksha, also a software engineer who loves Indian dancing, western music and teaching/training younger kids. Her son Aadarsh is studying Finance and enjoys playing bansuri, western music and discussions on political agenda and world economy. Dr. Dayal is a big fan of Indian ethnic arts/fabric and enjoys international traveling, designing, and supporting her children’s activities.

Dr. Ehtishamul Haq

Dr. Ehtishamul Haq presently works as Professor, at University of Kashmir, Did Masters (Biochemistry) from University of Kashmir (1995), earning Gold Medal from University of Kashmir. Pursued PhD from Postgraduate Institute of Medical Education and Research, completed it in the year 2000, received merit scholarship from PGIMER-Chandigarh during PhD programme.
2000–2005: Did Postdoctoral Fellowship at Medical University of South Carolina, USA, working mosltly on Krabbe’s disease and other Neuroinflammatory diseases.
He is presently working on the development of ensemble machine learning model(s) for prediction of putative epitopes for various viruses, ultimately to target them for vaccination.

Dr. Hari S. Sharma

PhD, DSc, FIEIC, FIABS

Hari Shankar Sharma is a Dutch Biomedical Scientist and Professor affiliated to the ErasmusMC, University Medical Centre, Rotterdam. He obtained High School diploma in 1974 (with Distinction) and studied Biological Sciences at AM University, Aligarh and obtained BSc (Honours in 1978) and MSc in Biochemistry (First Division in 1980). He then joined V.P. Chest Institute, Delhi University and received MPhil (1982) and PhD (1984) degrees in Biochemistry. In 2005, Dr. Sharma has been awarded DSc in Biochemistry for his single author work on 'Angiogenesis and Tissue Remodeling in the Heart and Lung Diseases'. After a short working experience as a Clinical Biochemist at the Armed Forces Transfusion Centre, Delhi.

Dr. Sharma moved to Germany in early 1985 to the prestigious Max-Planck Institute (MPI) for Biophysical Chemistry, Göttingen as a Post-Doctoral fellow in Molecular Biology (Director: Prof. Tom Jovin). In 1988, he accepted a junior group leader position at the MPI for Experimental Cardiology (Director: Prof. Wolfgang Schaper), Bad Nauheim, Germany. In early 1993, he moved to Netherlands to the Erasmus University Medical Centre, Rotterdam as an Assistant Professor and established a research group Cardio-pulmonary Molecular Biology and simultaneously participated in medical teaching. In 2010, he joined VUmc, Amsterdam as an Associate Professor and then moved back to Erasmus MC in 2020. Dr. Sharma also holds Visiting Professorship at the Era University Medical Institute, Lucknow and NIPER, Guwahati, India. His area of research includes: ‘Role of growth factors, cytokines and vasoactive agents in the pathogenesis of Heart & Lung diseases’.

Dr. Sharma has obtained a number of research grants, published 354 peer reviewed papers/book chapters/abstracts and cloned several genes including porcine VEGF and FGF-1. He has more than 35 years of teaching experience of Molecular & Cell Biology, Pharmacology and Laboratory Techniques to Medical/Master/PhD students. He has supervised 18 MD/MSc and 15 PhD students for their theses. He has organized 38 international conferences/symposia and has delivered 322 invited lectures worldwide.

Dr. Sharma has been bestowed with numerous awards/medalsincluding young Investigator Award of the International Society of Hypertension (Australia, 1994), Distinguished Service Award of Heart Care Foundation (India, 1998), Medal of Merit at the World congress of International Society of Heart Research (Canada, 2004), Masters of Indo-European Intervention Council (Netherland, 2010), Excellence in Research & Innovations Award of AMITY University (India, 2012). He serves as editor, editorial board member and referee for many reputed journals and funding agencies.

Dr. Sharma is the founder president of the Indian Academy of Biomedical Sciences, served as executive board member of Netherlands India Association, chair for Science & Technology council of GOPIO and member of several Indian, European and International scientific societies. Dr. Sharma is a dedicated member of COVID-19 research and management group of India (https://www.youtube.com/watch?v=cTZXWNBJ0gA). He is married to Dr. Belu Sharma and they have two sons. Dr. Sharma believes that scientists and the medical practitioners are not rivals, but students and teachers of each other as sharing of multidisciplinary knowledge makes breakthroughs in innovation and improved patient car